(): To meet the capital needs of Changzhou Flourish, provide a guarantee of no more than 50 million yuan for its application for comprehensive credit.
China Fortune Link, December 14-Yuxing Co., Ltd. announced that in order to meet the daily production and operation capital needs of Changzhou Fuluoli New Energy Materials Technology Co., Ltd., a holding subsidiary of the company, and ensure its sustained and stable development, the board of directors of the company agreed that the company should provide a guarantee of no more than RMB 50 million for Changzhou Fuluoli, a holding subsidiary, to apply for comprehensive credit from the bank. The guarantee method is credit guarantee, and the guarantee period is valid for one year from the date of deliberation and approval by the company’s shareholders’ meeting.
Yonghui Supermarket took over? Suspension for two days, Hongqi Chain intends to transfer control.
On the evening of December 13th, () announced that it had been informed by the actual controller and the concerted parties that the actual controller was planning the transfer of control. In view of the fact that the matter is under negotiation and there are still significant uncertainties, the shares of Hongqi Chain will be suspended from December 14th (Thursday), and the expected suspension time is two trading days.
Cao Shiru, chairman and general manager of Hongqi Chain, told the media: "The transfer of control right of Hongqi Chain is good for Hongqi Chain, which is conducive to the development of Hongqi Chain to a more stable, high-quality and efficient path."
Hongqi chain has long occupied the position of "top spot" in Sichuan convenience supermarket chain, and its new actual controller has caused market speculation.
The new receiver triggered market speculation.
Yonghui Supermarket, the second shareholder, cannot disclose it.
The transferee of the control right of Hongqi chain has become the most concerned point in the current capital market. At present, the market view focuses on three parties: (), Cao Zengjun and an unknown third party.
From the perspective of ownership structure, as of June 30, 2023, Cao Shiru, the actual controller of Hongqi Chain, held 24.08% of the shares, making it the largest shareholder; Yonghui Supermarket holds 21.00%, making it the second largest shareholder, and Cao Zengjun holds 3.55%, making it the fourth largest shareholder. Among them, Cao Shiru and Cao Zengjun are mother-child relations, and they are people acting in concert.
The shareholding ratio of Yonghui Supermarket and Cao Shiru is very close, and the Sichuan-Chongqing area is an important layout area of Yonghui Supermarket.
According to the semi-annual report of Yonghui Supermarket, as of June 30, 2023, Yonghui has 113 stores in Sichuan Province, which is second only to 147 in Chongqing and 139 in Fujian Province.
However, the current operation of Yonghui Supermarket is not optimistic. According to the latest three quarterly reports, Yonghui Supermarket achieved an operating income of 62.088 billion yuan in the first three quarters of 2023, down 12.44% year-on-year. In the third quarter, Yonghui Supermarket also suffered a loss of net profit of 321 million yuan.
On the same day that Hongqi Chain announced the suspension of trading, Yonghui Supermarket also announced the sale of assets. It is reported that Dalian Yujin Trading Co., Ltd. intends to purchase 389 million shares of Dalian Wanda Commercial Management Group Co., Ltd. from Yonghui Supermarket in cash, accounting for 1.43% of the total share capital of Wanda Commercial Management, with a transfer price of 4.53 billion yuan. Yonghui Supermarket said in the announcement that the purpose of this asset transaction is to revitalize the company’s assets, which is in line with the company’s strategy of reducing investment scale.
Regarding the transfer of control right of Hongqi chain, reporters from Nandu Bay Finance Agency called Hongqi chain and Yonghui Supermarket respectively. Hongqi chain told reporters, "At present, the transferee is still uncertain, and related matters are still in the negotiation stage." Yonghui Supermarket told reporters that "the relevant information is not convenient to disclose, which is subject to the announcement".
Sichuan Chain Supermarket Laoda
Hongqi chain operation is stable.
Hongqi Chain is the first listed convenience supermarket chain in China A-share market. It was founded on June 22nd, 2000, and has been in the top position of Sichuan convenience supermarket chain for 23 years. By June 30, 2023, Hongqi Chain had 3,592 stores.
Hongqi chain was founded by Cao Shiru, formerly known as Chengdu State-owned Hongqi Shopping Mall, which is located in the southwest movie capital of Yanshikou, Chengdu. In June, 2000, Cao Shiru left Hongqi Shopping Mall with tens of millions of debts and started his entrepreneurial journey. After years of hard work, Hongqi Chain officially landed in Shenzhen Stock Exchange on September 5, 2012, becoming the "first convenience store share" of A shares.
Since then, Hongqi Chain has successively acquired Hongyan Supermarket, Reciprocal Supermarket, Leshan Sihai Supermarket and 9010 Supermarket, further improving the market layout, and in 2020, it will go out of Sichuan and enter the national market.
Since listing, the chain operation of Hongqi has remained stable, and during 2012 -2022, it has achieved positive growth in operating income. In the latest three quarterly reports, Hongqi Chain achieved operating income of 7.641 billion yuan in the first three quarters, up 0.89% year-on-year, and realized net profit attributable to 407 million yuan, up 13.99% year-on-year.
It should be noted that in the third quarter of 2023, Hongqi Chain achieved revenue of 2.638 billion yuan, down 1.93% year-on-year. This is the second single-quarter revenue decline of Hongqi Chain since it went public in 2012. The last time it appeared in the first quarter of 2021, it was the outbreak in novel coronavirus.
In addition, on the evening of December 7, 2023, Hongqi Chain announced that it planned to sell the property located at No.221, Fair Heping Street, Wenjiang District, Chengdu to Chengdu Huangdajie Cleaning Service Co., Ltd., and the total transfer price was finally determined to be 20 million yuan through negotiation between the two parties. The funds obtained from the exchange will be used to supplement the working capital.
Metformin Engelje Tablets, a subsidiary of East China Pharmaceutical Co., Ltd., successfully renewed the national medical insurance catalogue.
() Announcement. On December 13, 2023, the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security issued "On Printing and Distributing"<国家基本医疗保险、工伤保险和生育保险药品目录(2023年)>Notice (No.30 [2023] of Medical Insurance). Metformin tablets (Ⅰ) of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhongmei Huadong"), a wholly-owned subsidiary of the company, were successfully renewed and continued to be included in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2023).
According to the published national medical insurance catalogue in 2023, the medical insurance payment standard for metformin tablets (I) in East China of China, the United States and China is 1.03 yuan (each tablet contains 500mg of metformin hydrochloride and 5mg of engeglinide), which is 14.88% lower than the medical insurance payment standard in the national medical insurance catalogue in 2022, and the limited payment scope is cancelled. The product agreement is valid from January 1, 2024 to December 31, 2025.
In addition, liraglutide injection in East China of China, the United States and the United States was transferred to the routine catalogue management, and the limited payment scope of liraglutide injection, Bering tablets and daptomycin for injection was adjusted compared with the national medical insurance catalogue in 2022.
Shanghai Kaibao: 93 drugs are included in the national medical insurance catalogue.
() Announcement, the company and its wholly-owned subsidiary Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd. ("Xinyi Pharmaceutical") have a total of 93 drugs included in the national medical insurance catalogue, including 50 in Class A and 43 in Class B. It mainly involves three exclusive varieties (Tanreqing Injection and Tanreqing Capsule, a subsidiary product of Qishen Capsule), and one exclusive dosage form (Doxofylline Capsule, a company product), which continues to enter the National Medical Insurance Catalogue (2023).
Among them, Tanreqing injection, the exclusive variety of the company, has been adjusted from "limited to severe patients in secondary and above medical institutions" to "limited to secondary and above medical institutions" in the National Medical Insurance Catalogue (2023); Tanreqing Capsule, the company’s exclusive variety, continued to be included in the National Medical Insurance Catalogue (2023) through negotiation. The medical insurance payment standard is 4.09 yuan /(0.4g/ capsule), and the agreement is valid from January 1, 2024 to December 31, 2025. After the expiration, it will be adjusted according to the relevant regulations of medical insurance. The inclusion of other products in the National Medical Insurance Catalogue (2023) remains unchanged from the National Medical Insurance Catalogue (2022).
Huadong Medicine: Metformin Englejing Tablets (Ⅰ) Renewed Contract and Included in National Medical Insurance Catalogue.
Huadong Pharmaceutical announced on the evening of December 14th that the metformin tablets (I) of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (hereinafter referred to as "Zhongmei Huadong"), a wholly-owned subsidiary of the company, were successfully renewed and continued to be included in the national medical insurance catalogue. The medical insurance payment standard was 1.03 yuan, which was 14.88% lower than the medical insurance payment standard in 2022. In addition, liraglutide injection in East China of China, the United States and the United States was transferred to the routine catalogue management, and the limited payment scope of liraglutide injection, Bering tablets and daptomycin for injection was adjusted compared with the national medical insurance catalogue in 2022.
Shanghai Kaibao: The company and its subsidiaries have 93 drugs listed in the national medical insurance catalogue.
Shanghai Kaibao announced on the evening of December 14th that 93 drugs of the company and its subsidiaries were included in the national medical insurance catalogue, including 50 drugs of Class A and 43 drugs of Class B.. Three exclusive varieties (Tanreqing injection and Tanreqing capsule, a subsidiary product of Qishen capsule) and one exclusive dosage form (doxofylline capsule, a company product) continue to enter the national medical insurance catalogue.
Wuliangye Group recognizes Wuliangye’s long-term value and plans to increase its shareholding by 400 million yuan to 800 million yuan.
On December 14th, () announced that Wuliangye Group plans to increase its shares with its own funds through centralized bidding and block trading, and the amount to be increased is not less than 400 million yuan and not more than 800 million yuan.
Wuliangye said that the increase plan is based on Wuliangye Group’s confidence in the company’s sustainable and stable development in the future and its recognition of the company’s long-term value.
According to the announcement, there is no price range for this increase plan, and the increase plan will be gradually implemented according to the overall trend of the capital market and the reasonable judgment of the company’s stock value.
According to the shareholder information of Wuliangye, up to now, Yibin Development Holding Group Co., Ltd., the controlling shareholder of Wuliangye, directly holds 34.43% of the company’s shares, and Wuliangye Group holds 20.40% of the company’s shares; Yibin Development Holding Group Co., Ltd. and Wuliangye Group are acting in concert, with a total shareholding ratio of 54.83%. Wuliangye said that this increase will not lead to changes in the controlling shareholder and actual controller of the company, and will not lead to the fact that the company’s equity distribution does not meet the listing conditions.
"For wine companies, the current market competition is fierce, the demand is weak, and the market is under great pressure. The increase in shares of head wine companies like Wuliangye can stabilize the stock price, maintain the corporate brand image, and enhance the confidence of shareholders. At the same time, the increase in holdings means that the company’s financial cash flow is abundant." Cai Xuefei, liquor industry analyst and general manager of Zhique Consulting, told the Securities Daily reporter.
According to the third quarterly report in 2023, from January to September this year, Wuliangye achieved an operating income of 62.536 billion yuan, a year-on-year increase of 12.11%; The net profit was 22.833 billion yuan, a year-on-year increase of 14.24%, which continued to show a steady development trend.
In addition to maintaining a steady growth in performance, Wuliangye’s cash flow also remained abundant. In the first three quarters, the net cash flow generated by Wuliangye’s operating activities was 22.389 billion yuan, a year-on-year increase of 107.58%.
Wang Xiaona, CEO of Beixinyuan, plans to increase the company’s stock by 3 million yuan to 5 million yuan.
() Announcement, Ms. Wang Xiaona, CEO and secretary of the board of directors of the company, based on her confidence in the company’s future sustainable development prospects and her recognition of the company’s investment value, plans to increase her holdings of the company’s shares within six months from the date of disclosure of this announcement, with an amount of not less than RMB 3 million and not more than RMB 5 million.
Beixinyuan: The CEO plans to increase his shareholding by RMB 3 million to RMB 5 million.
Beixinyuan announced on the evening of December 14th that Wang Xiaona, the company’s executive president and secretary of the board of directors, plans to increase the company’s shares by no less than 3 million yuan and no more than 5 million yuan. There is no price range for this increase.
The sale of commercial land by Great Wall Company, a subsidiary of Shenshen House A, was terminated.
Sham Shen Fang A announced that previously, the holding subsidiary Great Wall Estate Company,Inc (referred to as Great Wall Company for short) transferred the commercial land with plot number 5408-024-007 located in 774 N Broadway, Los Angeles, California 90012, and the United States to Voltera Power,LLC (the buyer) for 8.245 million US dollars.
On December 12, 2023, the company received the termination notice sent by the buyer on December 11, 2023 Pacific Time. The main contents of the notice are: the buyer has chosen to terminate the agreement according to the transaction agreement, which will take effect on December 11, 2023.
Huaxin Environmental Protection: 89.802 million restricted shares will be listed and circulated on December 18th.
() Announcement: The number of shares issued before the company’s initial public offering is 89.802 million shares, accounting for 29.64% of the company’s total share capital, and the listing date is Monday, December 18, 2023.
Guangting Information: Take the lead in undertaking the establishment of major scientific and technological special projects in Wuhan.
() On the evening of December 14th, it was announced that the project "Key Technologies and Applications of Intelligent Networked Automotive Basic Software", which was led by the company and participated by six units including Huazhong University of Science and Technology, was approved, with a total fund of 100 million yuan. Focusing on the key technologies and applications of intelligent networked automobile basic software, the project develops intelligent networked automobile operating system and middleware, builds a data-driven intelligent networked automobile cloud training and simulation platform, develops adaptive and optimized intelligent networked automobile function software algorithm, and develops high-security intelligent cockpit human-computer interaction; Relying on the foundation of automobile industry, the full-scene application of intelligent networked automobile basic software is realized.
Changchun Gaoxin: The application for clinical trial of GenSci125 for injection was approved.
() Announcement: Changchun Jinsai Pharmaceutical Co., Ltd. ("Jinsai Pharmaceutical"), a holding subsidiary of the company, received the Notice of Approval for Clinical Trial of Drugs about GenSci125 for Injection from National Medical Products Administration ("National Medical Products Administration"). According to the relevant provisions of the Drug Administration Law of People’s Republic of China (PRC), National Medical Products Administration agreed to carry out clinical trials on the indications of luteal support in assisted reproductive technology with GenSci125 for injection declared by Jinsai Pharmaceutical.
Changchun High-tech: The application for clinical trial of GenSci125 for injection by its holding subsidiary was approved.
Changchun hi-tech announced that the application for clinical trial of GenSci125 for injection by its holding subsidiary was approved.
Xingqi eye drops: 33 products continue to be included in the national medical insurance catalogue.
() Announcement, the company has a total of 33 products that continue to be included in the national medical insurance catalogue, including 8 Class A products and 25 Class B products. A variety of products such as cyclosporine eye drops (Ⅱ), compound electrolyte intraocular irrigation solution and sodium hyaluronate eye drops continue to be included in the National Medical Insurance Catalogue, and no products of the Company have withdrawn from the National Medical Insurance Catalogue this time.
Wanbangde: Huperzine A is recognized as an orphan drug by FDA, which will accelerate the company’s international strategic layout.
On the evening of December 13th, () announced that its subsidiary products were recognized by FDA as orphan drugs. Wanbangde Pharmaceutical, a wholly-owned subsidiary, received a letter of recognition from the US Food and Drug Administration (FDA) on the same day, and its huperzine A was recognized as an orphan drug by FDA for myasthenia gravis indications.
Huperzine A was recognized as an orphan drug by FDA, which is expected to accelerate the international strategic layout of Wanbond’s drugs. The announcement pointed out that the FDA has set up orphan drug qualification certification to encourage the development of drugs for treating rare diseases, and provided a series of incentives for the development of new drugs. The company will have the opportunity to enjoy US policy support in product development, registration and commercialization, including tax credit for clinical trial fees, exemption from new drug application fees, and exclusive market rights for seven years after product approval.
Orphan drugs help the strategic layout of internationalization
The so-called "orphan drug" refers to the drug for treating rare diseases. The FDA defines orphan drugs as drugs used to treat, prevent or diagnose rare diseases that affect less than 200,000 people in the United States, equivalent to about 6 cases per 10,000 people. In order to stimulate pharmaceutical companies’ motivation to research and develop drugs for rare diseases, the United States passed the Orphan Drugs Act (ODA) in 1983, which led to the birth of similar policies around the world. Today, orphan drugs have accounted for a large proportion of the newly approved drugs and biological agents by FDA every year. According to statistics, from 2004 to 2019, orphan drugs accounted for about one-third of the new batch of drugs.
It is predicted that from 2019 to 2024, the global orphan drug market is growing at a compound annual growth rate of about 12%, which is about twice that of the non-orphan drug market. By 2024, its market size will reach 242 billion US dollars, accounting for about 20% of the global prescription drug sales.
The enthusiasm of pharmaceutical companies for the research and development of orphan drugs largely comes from policy incentives. Among them, the most crucial point is that orphan drugs have a market monopoly period of 7 years compared with the market monopoly period of 5 years for general new drugs, and with the support of policies, they can achieve lower marketing costs and faster market share. At the same time, in the research and development stage, orphan drugs can get preferential policies in terms of approval threshold, research and development cycle, research and development expense subsidy, and regulatory approval.
Policy incentives have undoubtedly promoted the enthusiasm of pharmaceutical companies to develop orphan drugs. However, for pharmaceutical companies, obtaining orphan drug certification, completing follow-up studies and finally achieving listing is not only the "international recognition" of a pharmaceutical company’s R&D strength, but also the best example of the company’s courage to assume social responsibility.
Perhaps the more important significance of the orphan drug certification of Wanbangde Pharmaceutical Huperzine A lies in the FDA’s recognition of the company’s research and development strength. In the field of medicine, orphan drugs may be the first milestone of Wanbangde’s internationalization, but as early as 2018, Wanbangde cut into the field of medical devices, and the company has a continuous and in-depth layout in internationalization. It is understood that the company’s orthopedic equipment related products have already passed the FDA and European CE certification and are sold to the global market; Medical equipment and hospital engineering integration services focus on South Africa and southern African markets; Disposable sterile medical polymer devices have a production capacity of 1.2 billion pieces/year. All kinds of syringes have been brought into the domestic centralized purchasing market, and the company is also actively developing its own brand business for the international market.
Huperzine A with a potential of 2 billion.
The certification of orphan drugs is undoubtedly a great help to Wanbangde’s international strategic layout, and huperzine A itself is an excellent variety to return to the attention of drugs. It is understood that huperzine A is a new effective monomer of lycopodium alkaloids isolated by Chinese scientists in 1982. Its essence is a reversible acetylcholinesterase (AChE) inhibitor, which is often used to treat benign memory disorders and mild to moderate senile dementia in clinic, and can effectively improve patients’ memory, learning ability and cognitive behavior ability. At the same time, the drug has also been proved to be used for the treatment of myasthenia gravis, which is also the indication range of the company’s orphan drug certification.
In the product layout of Wanbangde Pharmaceutical, huperzine A injection has been on the market for many years, which is the leading product in the field of nervous system medication, and is considered to be one of the most effective drugs to improve cognitive function and memory impairment and treat Alzheimer’s disease. It is reported that the huperzine A injection of the company is the first product at home and abroad, and has won the second prize of national technological invention, and has been included in the expert consensus and clinical guidelines in many neurosurgical fields. In more than ten expert consensus and diagnosis and treatment guidelines, such as Expert Consensus of Accelerated Rehabilitation in Neurosurgery (ERAS), Clinical Pathway Interpretation-Rehabilitation Medicine-Rehabilitation of Craniocerebral Injury in 2022, Clinical Pathway Interpretation-Neurology-Cerebral Infarction, etc. Driven by factors such as clinical efficacy and advantages of injection form, the company’s income of Huperzine A injection has steadily increased in the past two years, and its sales income reached 129 million yuan in 2022, up by 15.76% year-on-year.
What’s more worth mentioning is that the clinical trial of huperzine A controlled release tablets jointly developed by Wanbangde and the academician team is being implemented. According to soochow securities’s analysis, oral huperzine A controlled-release tablets can be administered once a day. If it can be successfully marketed in the future, it will greatly improve the compliance and convenience of senile dementia patients, and it is expected to become another growth pole of the company. Soochow securities pointed out that the indications of Huperzine A include not only the approved memory disorder, but also many application scenarios such as senile dementia and myasthenia gravis. With the further laying of the company’s channels, Huperzine A injection is expected to achieve a rapid growth of 60% to 90%, and eventually become a large variety with a revenue scale of 2 billion.
The approval of the FDA orphan drug certification will not only promote the subsequent research and development and commercialization of huperzine A, but also provide a strong boost for Wanbond, providing a strong boost for the company’s international strategic layout and subsequent drug research and development. At the same time, however, the company’s announcement also pointed out that due to the characteristics of high risk and high added value in drug research and development, the period from early drug research and development to clinical trial approval to production is long and there are many links, which are easily affected by some uncertain factors. This time, the company obtained the qualification of orphan drugs, and the company still needs to apply for clinical trials of huperzine A for myasthenia gravis indications according to the requirements of FDA regulations. The approval of clinical trials, clinical trial results and marketing applications are uncertain.
Xingqi Eye Drops: A total of 33 products continue to be included in the national medical insurance catalogue.
Xingqi Ophthalmology announced on the evening of December 14th that 33 products of the company continued to be included in the national medical insurance catalogue, including 8 products of Class A and 25 products of Class B.. Cyclosporine eye drops (Ⅱ), compound electrolyte eye rinse, sodium hyaluronate eye drops and other products continue to be included in the national medical insurance catalogue, and no products of the company have withdrawn from the national medical insurance catalogue this time.
The CEO of Beixinyuan plans to increase the company’s shares by 3 million to 5 million yuan.
Beixinyuan announced that Wang Xiaona, the company’s CEO and secretary of the board of directors, plans to increase the company’s shares within six months from the date of announcement, with an increase of not less than 3 million yuan and not more than 5 million yuan. There is no price range for this increase.
The control right of Hongqi chain will change hands, and the answer will be revealed in two days at the earliest.
On the evening of December 13, Hongqi Chain issued an announcement on planning the change of control rights and suspension of trading, and began to suspend trading on December 14. As for who will take over the control of Hongqi chain, there is speculation in the market that it is Yonghui Supermarket, the second largest shareholder of the company, or other third parties. Whose control right of the Red Flag chain will eventually fall, and the answer may be announced soon.
Cao Shiru said that it is conducive to the long-term development of the company.
According to the announcement, Chengdu Hongqi Chain Co., Ltd. received a notice from the actual controller and concerted parties of the company on December 13, 2023, and the actual controller was planning the transfer of control. In view of the fact that the matter is still under negotiation and there are still significant uncertainties, according to the Rules for Listing of Stocks of Shenzhen Stock Exchange and the Guidelines for Self-regulation of Listed Companies of Shenzhen Stock Exchange No.6 on Suspension and Resumption of Trading, in order to ensure fair information disclosure, safeguard the interests of investors and avoid abnormal fluctuations in the company’s share price, the company applied to Shenzhen Stock Exchange for suspension of trading since the market opened on Thursday, December 14, 2023. The expected suspension time is two trading days.
Regarding the change of planning control right, Cao Shiru, chairman and general manager of Hongqi chain, said that the transfer of control right of Hongqi chain is conducive to the development of Hongqi chain to a more stable, high-quality and efficient path, which is a good thing for the long-term development of listed companies.
Will Yonghui Supermarket, the second largest shareholder, take over?
According to public information, Cao Shiru and Cao Zengjun are real controllers and concerted actions of Hongqi Chain, and Cao Zengjun is the son of Cao Shiru. By the end of the third quarter, Cao Shiru held 327.42 million shares of Hongqi Chain, accounting for 24.08% of the total share capital, making him the largest shareholder. Cao Zengjun holds 48.28 million shares, accounting for 3.55% of the total share capital. Before the suspension, Hongqi Chain closed at 5.37 yuan per share, and the total stock market value of Cao Shiru and Cao Zengjun reached 2.017 billion yuan.
As for who will take over the actual control right, there is speculation in the market that it is Yonghui Supermarket, the second largest shareholder of Hongqi Chain, or other third parties. It can be seen that at the end of December 2017, Yonghui Supermarket announced the acquisition of 12% shares of Hongqi Chain at the price of 5.8 yuan per share, with a total price of 947 million yuan. Soon after, Yonghui Supermarket once again acquired 9% shares of Hongqi Chain at the price of 5.8 yuan per share. In just half a month, Yonghui Supermarket acquired 21% equity of Hongqi Chain through continuous agreement transfer, becoming the second largest shareholder of the company. After Yonghui Supermarket announced on January 3, 2018 that it had completed the transfer of the equity of Hongqi Chain, Yonghui Supermarket signed a strategic cooperation framework agreement with Hongqi Chain and Zhongmin Future Holding Group Co., Ltd., intending to cooperate in retail outlets’ value-added, retail model innovation, inclusive finance, home care for the aged and community logistics. Give full play to their respective advantages under the principles of equality, fairness, openness and marketization, strengthen all-round cooperation, form integration and complementarity of advantages, and achieve mutual benefit and win-win results.
Revenue in the first three quarters of this year exceeded 7.6 billion yuan.
As the "first convenience store share" of A shares, Hongqi Chain was listed on the small and medium-sized board market of Shenzhen Stock Exchange on September 5, 2012, and its performance has been relatively stable. With the further development momentum after listing, since 2015, the company has successively acquired Hongyan Supermarket, Mutual Supermarket, Leshan Sihai Supermarket and 9010 Supermarket to further improve the network layout.
Deeply ploughing the local Hongqi chain has not given up exploring the market outside the province. In September 2020, the company and Lanzhou State-owned Limin Asset Management Group Co., Ltd. jointly established "Hongqi Convenience". After years of development, by the first half of 2023, the number of Hongqi stores in Gansu had rapidly increased to 97.
Judging from the performance in recent years, after three years of epidemic, the performance of Hongqi chain fluctuated slightly. In 2023, the company experienced a recovery growth. In the first three quarters of this year, the company achieved operating income of 7.64 billion yuan, a year-on-year increase of 0.89%. The net profit was 407 million yuan, a year-on-year increase of 13.99%. The growth rate of net profit of Hongqi Chain was significantly higher than that of operating income in the same period, and its profitability rebounded significantly.
In the short term, the recovery of consumption will drive the performance of Hongqi chain to improve. In the long run, the penetration rate of convenience stores in Chengdu is still low, and the company still has a lot of room for expansion. With the encryption of the number of stores, it is expected to further enhance the company’s brand awareness and form scale effect. The company’s stores are all directly operated, which is conducive to the polishing of the single-store model and forms a standard and reproducible shop opening template. At present, the company has opened 97 Gansu Hongqi convenience stores in Gansu through management mode, and it is expected to continue to form large-scale expansion in the form of franchise stores in the future, driving steady growth in performance.
The control of the Red Flag chain may change hands, and who will eventually take control will reveal the answer in two days at the earliest.
Xingqi Eye Drops: A total of 33 products of the company continue to be included in the national medical insurance catalogue.
On December 14th, Xingqi Ophthalmology Shenzhen Stock Exchange announced that a total of 33 products of the company continued to be included in the national medical insurance catalogue, including 8 products of Class A and 25 products of Class B.. A variety of products such as cyclosporine eye drops (Ⅱ), compound electrolyte intraocular irrigation solution and sodium hyaluronate eye drops continue to be included in the National Medical Insurance Catalogue, and no products of the Company have withdrawn from the National Medical Insurance Catalogue this time.
Shengbang shares were selected as national intellectual property advantage enterprises.
() Announcement, the company was identified as "National Intellectual Property Advantage Enterprise", and the cultivation period was from November 2023 to October 2026.
Huadong medicine: a wholly-owned subsidiary product, metformin tablets (Ⅰ) The renewal of the national medical insurance catalogue was successful.
Huadong Pharmaceutical announced that the metformin tablets (I) of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, were successfully renewed and continued to be included in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2023).
Yan Hua, the actual controller of this information, pledged 31.6 million shares.
() Announcement: Yan Hua, the controlling shareholder and actual controller of the company, has handled the pledge business of some shares of the company he holds, and this time he pledged 31.6 million shares.
Dongning Bohong, a Zhongyi technology stock, can reduce its holdings by 1%.
() Announcement: From November 20, 2023 to December 14, 2023, Ningbo Hongneng, the shareholder of the company, reduced its holdings of 1.286 million shares by centralized bidding and block trading, accounting for 1% of the company’s total share capital.
Starnet Ruijie: On December 14th, it repurchased 1059999 shares of the company for the first time.
On the evening of December 14th, () announced that on December 14th, 2023, the company repurchased the company’s shares through the special securities account for stock repurchase for the first time by centralized bidding. The number of repurchased shares was 1,059,999 shares, accounting for 0.1788% of the company’s current total share capital. The highest transaction price was 18.85 yuan/share, the lowest transaction price was 18.68 yuan/share, and the total transaction amount was 1991388.
Feilong shares: use 20 million yuan of idle self-owned funds for cash management.
On the evening of December 14th, () announced that the company had recently used idle self-owned funds for cash management. This time, a total of 1 cash management product was purchased. The signing institution was Shenwan () Co., Ltd., and the product name was Shenwan Hongyuan Securities Co., Ltd. Long Ding National Debt Jiaying New Guest Exclusive (listed company) 71-phase income voucher product. The product type was principal-guaranteed, and the product subscription amount was 20 million yuan. The starting date was December 12, 2023.
Xinbo shares: 3,370,786 restricted shares will be listed and circulated on December 18th.
On the evening of December 14th, () issued a suggestive announcement on the listing and circulation of some restricted shares in non-public offering. According to the announcement, the number of shares with restricted shares released this time is 3,370,786 shares, accounting for 2.29% of the company’s total share capital; Date of listing and circulation of the shares released from restricted sale this time: Monday, December 18, 2023.
Qiaoyin Co., Ltd. pre-won the bid for related environmental protection projects of about 82.05 million yuan.
() Announced, recently, the company pre-won the bid for 2024 "Comprehensive Project of Urban Expressway Cleaning, Snow and Ice Removal and Facility Cleaning" in Urumqi, Xinjiang Uygur Autonomous Region. It is estimated that the total bid amount is about 82.05 million yuan.
Huadong Medicine: The subsidiary product Metformin Engelje Tablets (Ⅰ) was renewed and included in the National Medical Insurance Catalogue in 2023.
On the evening of December 14, East China Medicine announced that on December 13, 2023, the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security issued the "On Printing and Distributing"<国家基本医疗保险、工伤保险和生育保险药品目录(2023年)>Notice (No.30 [2023] of Medical Insurance). Metformin tablets (I) of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, were successfully renewed and continued to be included in the National Drug List of Basic Medical Insurance, Work Injury Insurance and Maternity Insurance (2023) (referred to as "2023 National Medical Insurance Catalogue").
Meifeng, Sichuan: Repurchase the cancelled shares and complete the industrial and commercial change registration.
On the evening of December 14th, () announced that recently, the company had completed the industrial and commercial change registration procedures and obtained the business license renewed by Suining Municipal Market Supervision Administration with a registered capital of 573,737,680 yuan.
The company held the "Second Extraordinary General Meeting of Shareholders in 2023" on November 16, 2023, and reviewed and approved the "Amendment"<公司章程>The motion ". In view of the fact that the company’s share repurchase plan has been implemented, all the repurchased shares of 11,986,072 shares are used for cancellation to reduce the registered capital, so it is necessary to modify the registered capital and the total number of shares in the Articles of Association and register the relevant industrial and commercial changes accordingly. After the cancellation procedures are completed, the total number of shares of the company is reduced from 585,723,752 to 573,737,680, and the registered capital of the company is reduced from RMB 585,723,752 to RMB 573,737,680.
Will REITs, the first batch of affordable new energy power stations, be released? () REITs to be declared for infrastructure public offering: participating in the subscription of not less than 20% of the fund shares.
On December 13th, Jing ‘ao Solar Technology Co., Ltd. (referred to as "Jing ‘ao Technology", 002459.SZ) announced that Jing ‘ao Technology intends to use some of its photovoltaic power generation projects as infrastructure assets to carry out the declaration and issuance of public offering of infrastructure securities investment funds (referred to as "infrastructure public offering REITs"). As a sponsor, the company will participate in the subscription of not less than 20% of the REITs fund share in infrastructure public offering according to the requirements of laws, regulations and regulatory rules and combined with market conditions.
On December 14th, related persons of Jing ‘ao Technology told the reporter of China Times that the public offering of REITs in infrastructure will help the company to further broaden financing channels, introduce innovative financial instruments, effectively revitalize existing operational infrastructure assets, improve asset turnover speed, reduce financial leverage and optimize the company’s asset-liability structure.
It is worth mentioning that the Chaoyang project is the first batch of affordable photovoltaic power station projects in China among the underlying assets of the public offering REITs of Jing ‘ao science and technology infrastructure, and this infrastructure public offering REITs is expected to become the first batch of affordable new energy power station REITs projects in the market. The above-mentioned stakeholders of Jingao Technology believe that the development prospect of photovoltaic infrastructure REITs is very broad, and "what form will be planned in the future according to the plan for how to deal with the remaining stock of power station assets".
Affordable internet access projects are the underlying assets.
According to the announcement issued by Jingao Technology on the evening of December 13th, the company intends to select Kangbao Jingneng Project (hereinafter referred to as Kangbao Project) held by kangbao county Jingneng New Energy Development Co., Ltd. (hereinafter referred to as Kangbao Jingneng) and Chaoyang Xinghua Fair-price Internet Access Project (hereinafter referred to as Chaoyang Project) held by Chaoyang Xinghua Solar Power Generation Co., Ltd. (hereinafter referred to as Chaoyang Xinghua) as the target assets to declare and issue REITs for infrastructure public offering.
Among them, Kangbao Project is located in kangbao county, Zhangjiakou City, Hebei Province, which belongs to the photovoltaic power generation poverty alleviation subsidy project with a construction scale of 20MW, invested and developed by kangbao county Jingneng New Energy Development Co., Ltd.; Chaoyang project, located in Chaoyang county, Chaoyang city, Liaoning province, belongs to photovoltaic power generation parity online project with a construction scale of 295.425MW, which is invested and developed by Chaoyang Xinghua Solar Power Generation Co., Ltd.
The specific transaction process includes setting up infrastructure public offering REITs, participating in the strategic placement of infrastructure public offering REITs, setting up a special plan for infrastructure asset support, transferring the equity of the project company and arranging the operation and management of infrastructure projects.
The above-mentioned projects held by the company are the underlying assets of the pool, and they are declared by the National Development and Reform Commission in accordance with the relevant policy documents of infrastructure public offering REITs. After being recommended by the National Development and Reform Commission to the China Securities Regulatory Commission, the manager of Public Offering of Fund will apply to the China Securities Regulatory Commission for registration of infrastructure public offering REITs and listing on the Shenzhen Stock Exchange. After obtaining the registration documents, the administrator of Public Offering of Fund will make a public offering together with the financial advisor.
As a sponsor, Jingao Technology will participate in the subscription of not less than 20% of the infrastructure public REITs fund share according to the requirements of laws, regulations and regulatory rules and combined with market conditions. Infrastructure public offering REITs will acquire full ownership, control and disposal rights of infrastructure projects by fully subscribing for infrastructure asset-backed securities issued by special plans.
In the process of transferring the equity of the project company, in the Kangbao project, the special plan is to acquire 100% equity of SPV Company, a special purpose carrier established by the company, and acquire 100% equity of Kangbao project from Jing ‘ao Solar Investment (China) Co., Ltd. through SPV Company. Kangbaojing can complete the reverse absorption merger with SPV Company. After the merger, Kangbaojing can undertake all the assets and debts of SPV Company as the surviving entity, and the shareholders of Kangbaojing can be changed from SPV Company to a special plan; In the Chaoyang project, the special plan is to acquire 100% equity of Chaoyang project from Chaoyang Longsheng Solar Power Generation Co., Ltd.
In terms of infrastructure project operation and management arrangement, Huaan Fund Management Co., Ltd. is the fund manager, which operates in a closed mode during the duration. The fund scale is determined according to the evaluation value of infrastructure assets and the issuance results of infrastructure public offering REITs, and the term is tentatively set at 25 years. The original owners include Jing ‘ao Solar Investment (China) Co., Ltd. (original owner I) and Chaoyang Longsheng Solar Power Generation Co., Ltd. (original owner II). The Fund mainly invests in all shares of asset-backed securities in the target infrastructure, and ultimately holds 100% equity of Kangbao Jingneng and 100% equity of Chaoyang Xinghua.
The prospect of infrastructure public offering REITs can be expected
"Launching infrastructure public offering REITs will help us to further broaden financing channels, introduce innovative financial instruments, effectively revitalize existing operational infrastructure assets, improve asset turnover speed, reduce financial leverage, optimize the company’s asset-liability structure, and promote the company’s investment in new energy fields. A virtuous circle will help the smart energy division transform asset-light strategy and enhance the company’s ability to continue operations." At noon on December 14th, a related person from Jingao Technology told the reporter of China Times.
This person believes that the development prospect of photovoltaic infrastructure REITs is very broad. This is mainly because photovoltaic power generation is a clean and renewable energy source, which meets the global demand for environmental protection and sustainable development; With the continuous progress of technology and the reduction of cost, the competitiveness of photovoltaic power generation has been continuously improved, and the photovoltaic industry has received increasing attention and investment, which provides more investment opportunities and potential for photovoltaic infrastructure REITs. At the same time, governments all over the world are actively promoting the development of photovoltaic industry, encouraging and supporting enterprises to invest in photovoltaic power generation projects, which may provide more policy support and guarantee for photovoltaic infrastructure REITs. In addition, REITs, as an innovative financial tool, can provide financing support for renewable energy projects through the capital market.
From the policy background, in June, 2021, the National Development and Reform Commission issued the Notice on Further Improving the Pilot Work of Real Estate Investment Trust Funds (REITs) in Infrastructure, which included wind power and photovoltaic power generation in the pilot industries, and proposed giving priority to supporting projects of leading enterprises with certain popularity and influence. Since the beginning of this year, the National Development and Reform Commission and the China Securities Regulatory Commission have issued several notices to encourage and support the development of REITs, expand the issuance scale of infrastructure REITs, and expand private investment.
The reporter of China Times noted that on March 14th this year, the first single property right photovoltaic infrastructure REITs in China-AVIC Jingneng Photovoltaic REITs were put on sale, and the subscription amount of public investors was as high as 29.254 billion yuan, which was 158 times higher than the initial public offering scale of 185 million yuan. On March 29th, AVIC Jingneng Photovoltaic REIT was listed on the Shanghai Stock Exchange, with an increase of 12.37% on the first day.
At the beginning of December, Jingneng International revealed in the investor relations activities in the third quarter of 2023 that since the listing of AVIC Jingneng Photovoltaic Closed Infrastructure Securities Investment Fund for more than seven months, the project operation has been stable and efficient, with good operating conditions. The secondary market of products performed well, and the first dividend was paid in the first year of listing, with a cash distribution rate of 10.96%.
Bai Wenxi, chief economist of IPG China, also told the reporter of China Times that with the rapid development of China’s economy and the continuous advancement of infrastructure construction, there are more and more large-scale infrastructure projects with stable cash flow and long-term investment potential. "The construction and operation of these projects require a lot of capital investment, and public offering of REITs can provide an effective source of funds for these projects". With the development and perfection of China’s capital market, investors’ demand for diversified investment is getting higher and higher. Public offering of REITs can provide investors with an investment choice.
Undoubtedly, as a financial innovation mode with important demonstration significance, infrastructure public offering REITs has many advantages. According to the above-mentioned stakeholders of Jingao Technology, with the continuous development and improvement of the capital market, photovoltaic infrastructure REITs will get more investment opportunities and financial support. However, it also stressed to reporters that while enterprises are optimistic about the development prospects of photovoltaic infrastructure REITs, they still need to pay attention to the risks and challenges: "Investors need to pay comprehensive attention to market dynamics, policy changes and technological progress and make rational investment decisions."
Qiaoyin shares: the pre-bid is about 82.05 million yuan for related environmental protection projects in Urumqi.
On the evening of December 14th, Qiaoyin announced that the company had won the bid of about 82.05 million yuan for the comprehensive project of urban expressway cleaning, ice and snow removal and facility cleaning in Urumqi in 2024. The winning bid amount is 27.3502 million yuan a year, and the service period is 3 years, with a total amount of 82.0506 million yuan.
() It is planned to carry out repurchase with over-raised funds of 30 million yuan to 60 million yuan, and the repurchase price shall not exceed 28 yuan/share.
Jianke shares announced that the company intends to use part of the over-raised funds to buy back the company’s shares in a centralized bidding transaction for the implementation of equity incentives or employee stock ownership plans. The total amount of repurchase funds is not less than 30 million yuan (inclusive) and not more than 60 million yuan (inclusive). The price of repurchased shares shall not exceed 28 yuan/share (inclusive). The time limit for repurchasing shares is within 12 months from the date when the company’s board of directors deliberated and approved the plan for repurchasing shares.
Jianke Co., Ltd. plans to introduce employee stock ownership platforms for its subsidiaries’ crown label testing and Shiyi quality inspection respectively.
Jianke Co., Ltd. announced that in order to meet the business development needs of its holding subsidiaries, Guanbiao (Shanghai) Testing Technology Co., Ltd. (hereinafter referred to as "Guanbiao Testing") and Chongqing Shiyi Product Quality Inspection Co., Ltd. (hereinafter referred to as "Shiyi Quality Inspection"), the company intends to implement employee stock ownership by introducing an employee stock ownership platform to increase capital or transfer old shares to subsidiaries.
Among them, Guanbiao Testing intends to introduce Changzhou Jinping Venture Capital Partnership (Limited Partnership) (tentative name, referred to as "Jinping Investment"), an employee stock ownership platform, through capital increase. Jinping Investment intends to increase the capital of Guanbiao Testing by no more than 5.55 million yuan, and the newly-increased registered capital of subscribing Guanbiao Testing by no more than 370,000 yuan. The excess of 5.18 million yuan is included in the capital reserve of Guanbiao Testing. The capital increase is priced at 15 yuan/registered capital, and the transaction capital is the own capital of Jinping Investment. The company waives the priority to subscribe for capital contribution.
Rongce (Chongqing) Technology Co., Ltd. (hereinafter referred to as "Rongce Technology"), a wholly-owned subsidiary of the company, intends to transfer 8.71% of the shares of Shiyi Quality Inspection Company to Changzhou Lapras Venture Capital Partnership (Limited Partnership) (tentatively named as "Lapras Investment"), which is an employee-owned platform, at a price not exceeding 6.29 million yuan. The transfer price is 0.5 yuan/registered capital, and the transaction capital is the self-owned capital invested by Lapras.
It is reported that this matter is conducive to attracting and retaining outstanding talents, fully mobilizing the enthusiasm and creativity of the management team and core employees, and promoting the common growth and development of employees and the company.
Changchun High-tech: The application for clinical trial of GenSci125 for injection of Jinsai Pharmaceutical was approved.
China Fortune Link, December 14-Changchun Hi-tech announced that recently, Jinsai Pharmaceutical, a holding subsidiary of the company, received the Notice of Approval for Clinical Trials of Drugs about GenSci125 for Injection from National Medical Products Administration. National Medical Products Administration agreed to the clinical trial of GenSci125 for injection declared by Jinsai Pharmaceutical Co., Ltd. on the indications for luteal support in assisted reproductive technology. After GenSci125 for injection is approved for clinical trial, the company will organize clinical research in strict accordance with relevant national laws, regulations and rules.
Longli Technology: 19,920,300 restricted shares will be listed and circulated on December 18th.
() Prominent announcement on the release of restricted shares issued to specific objects and their listing and circulation. The number of shares released this time is 19,920,300 shares issued by the company to specific objects, accounting for 8.7524% of the company’s current total share capital, and the listing and circulation date is Monday, December 18, 2023.
Jianke shares: it is planned to buy back shares from 30 million yuan to 60 million yuan.
Jianke Co., Ltd. announced on the evening of December 14th that the company intends to use part of the over-raised funds to buy back the company’s shares by centralized bidding. The total amount of the repurchased funds is not less than 30 million yuan and not more than 60 million yuan, and the price of the repurchased shares is not more than 28 yuan/share. The repurchased shares will be used to implement equity incentives or employee stock ownership plans.
Plus code high-efficiency solar cell module manufacturing () It is planned to build a new 4.6GW HJT battery production project of 2.1 billion yuan.
Aikang Technology announced that Ganzhou Aikang Optoelectronic Technology Co., Ltd. (hereinafter referred to as "Ganzhou Aikang Optoelectronic"), the company’s wholly-owned grandson company, plans to invest in the construction of a 4.6GW HJT battery production project, with a total investment of 2.1 billion yuan in fixed assets (except the main equipment, the investment in fixed assets such as land, civil engineering and electromechanical facilities has been completed), and a new 600MW and five 800MW HJT battery production lines will be built. The company plans to complete the entry of the main equipment of the first HJT battery production line in January 2024.
According to the announcement, the company will continue to increase the manufacturing of high-efficiency solar cell modules, focus on heterojunction technology, and further upgrade the battery production line. In the new round of competition for upgrading P-type to N-type technology in the photovoltaic industry, it is expected to continue to gain favorable market competition position by virtue of its capacity structure advantages.
Yalian Development: The CSRC decided to file a case against the company for allegedly violating the letter.
() On the evening of December 14th, it was announced that the company had received a notice of filing a case issued by the China Securities Regulatory Commission, and the China Securities Regulatory Commission decided to file a case against the company because the company was suspected of violating laws and regulations in information disclosure.
Yalian Development: The company received a notice of filing a case from the China Securities Regulatory Commission because it was suspected of illegal information disclosure.
Yalian Development Announcement: On December 14th, 2023, the company received the Notice of Filing a Case by China Securities Regulatory Commission issued by China Securities Regulatory Commission (hereinafter referred to as "China Securities Regulatory Commission"). Because the company was suspected of violating laws and regulations in information disclosure, the China Securities Regulatory Commission decided to file a case for the company according to the People’s Republic of China (PRC) Securities Law, the Administrative Punishment Law of the People’s Republic of China and other laws and regulations.
Golden mantis won the first place in the decoration and design category of China architectural decoration industry in 2022.
() Announcement, the results of the "2022 China Building Decoration Association Industry Comprehensive Data Statistics" organized by China Building Decoration Association were officially announced, and the company won the first place in the decoration category and the first place in the design category.
Aikang Technology: Sun Company plans to invest 2.1 billion yuan to build a 4.6GWHJT battery production project.
Aikang Technology announced that Ganzhou Aikang Optoelectronic Technology Co., Ltd., a wholly-owned grandson company, plans to invest in the construction of a 4.6GWHJT battery production project. The total investment in fixed assets of the project is 2.1 billion yuan, and one 600MW and five 800MWHJT battery production lines are newly built.
Mankun Technology: It is planned to invest no more than US$ 70 million to build a new production base in Thailand.
() Announcement, the company plans to invest in building a new production base in Thailand with its own funds and self-raised funds not exceeding 70 million US dollars, including but not limited to the establishment of a new company, the purchase of land, the purchase and construction of fixed assets and other related matters.
Ruide Intelligent plans to set up a new Vietnamese Sun Company to build overseas production capacity.
() Announcement, the company plans to increase the capital of US$ 5,000,000 to its wholly-owned subsidiary Reed Development (Hong Kong Reed) Co., Ltd. (hereinafter referred to as "Hong Kong Reed") with its own funds, all of which will be used for Hong Kong Reed’s newly established Sun Company Reed Intelligent Technology (Vietnam) Co., Ltd. (tentatively named "Reed Intelligent (Vietnam)" with a registered capital of US$ 3,500,000), and Reed Intelligent (Vietnam) will invest in the construction of surrounding companies in Vietnam.
According to the announcement, the company intends to increase capital to Hong Kong Reed, a wholly-owned subsidiary, to set up Sun Company overseas to build new overseas production capacity, expand overseas business layout and enhance the company’s comprehensive strength, thus promoting the smooth progress of overseas business.
Total electroacoustic: it is planned to invest 1.04 billion yuan to build a production base project of electroacoustic components and electroacoustic components in Yiwu.
() Announcement, it is planned to raise funds by means of its own funds, introducing strategic investors to holding subsidiaries, bank loans, etc. Through a total investment of 1.04 billion yuan in Zhejiang, it will invest in the construction of electroacoustic components and electroacoustic components production base project in Yiwu City, and build a production line with an annual output of 20 million cars and 14 million mobile phones.
Aikang Technology: It plans to invest 2.1 billion yuan to build a 4.6GW HJT battery production project.
On the evening of December 14th, Aikang Technology announced that up to now, the company’s HJT components are on hand with an order of about 2.95GW, and the company’s own production capacity of HJT batteries can’t meet the order demand. The company’s wholly-owned grandson, Ganzhou Aikang Optoelectronics, plans to invest in the construction of a 4.6GW HJT battery production project, with a total investment of 2.1 billion yuan in fixed assets. One 600MW and five 800MW HJT battery production lines will be newly built in the project, and it is planned to increase the production capacity in batches and line by line according to the order.
Xingqi Ophthalmology: A total of 33 products of the company continue to be included in the national medical insurance catalogue.
Xingqi Ophthalmology Announcement, on December 13, 2023, the National Medical Insurance Bureau and the Ministry of Human Resources and Social Security issued the "On Printing and Distributing"<国家基本医疗保险、工伤保险和生育保险药品目录(2023年)>Notice ",the company has a total of 33 products continue to be included in the national medical insurance catalogue, including 8 Class A products and 25 Class B products. A variety of products such as cyclosporine eye drops (Ⅱ), compound electrolyte intraocular irrigation solution and sodium hyaluronate eye drops continue to be included in the National Medical Insurance Catalogue, and no products of the Company have withdrawn from the National Medical Insurance Catalogue this time.
Asian Union Development: It was filed by the Securities and Futures Commission on suspicion of violating laws and regulations.
Yalian Development Announcement: On December 14th, 2023, the company received the Notice of Filing a Case by China Securities Regulatory Commission issued by China Securities Regulatory Commission, and China Securities Regulatory Commission decided to file a case for the company because it was suspected of illegal information disclosure.
Mankun Technology plans to invest no more than US$ 70 million to build a production base in Thailand and improve its overseas layout.
Mankun Technology announced that the board of directors of the company reviewed and approved the Proposal on Investing in a New Production Base in Thailand, and the company will invest in a new production base in Thailand with its own funds and self-raised funds not exceeding 70 million US dollars, including but not limited to the establishment of a new company, the purchase of land, the purchase and construction of fixed assets and other related matters.
It is reported that the company’s investment in building a production base in Thailand this time is conducive to improving the layout of the company’s overseas production bases and establishing the supply capacity of overseas products and services.
Starnet Ruijie: The total transaction amount of 0.1788% shares repurchased for the first time is about 19.9138 million yuan.
China Fortune Link, December 14-Starnet Ruijie announced that the company repurchased the company’s shares by centralized bidding for the first time through the special securities account for stock repurchase, and the number of repurchased shares was 1,059,999, accounting for 0.1788% of the company’s current total share capital. The highest transaction price was 18.85 yuan/share, the lowest transaction price was 18.68 yuan/share, and the total transaction amount was 19,913,849.
Digital Zhengtong plans to set up wholly-owned subsidiaries in Xiong ‘an and other places.
() Announcement, the company plans to invest and set up subsidiaries in xiong’an new area, Hebei Province, Yichang City, Hubei Province and Fuzhou City, Fujian Province. Among them, Xiong ‘an subsidiary plans to register as Hebei Xiong ‘an Digital Zhengtong Technology Co., Ltd., with a registered capital of 10 million yuan, and subscribed capital with the company’s own funds, with a shareholding ratio of 100%; Yichang subsidiary intends to register its name as Yichang Digital Zhengtong Technology Co., Ltd., with a registered capital of 10 million yuan, and subscribed capital with the company’s own funds, with a shareholding ratio of 100%; Fuzhou subsidiary intends to register its name as Fujian Digital Zhengtong Technology Co., Ltd., with a registered capital of 50 million yuan, and subscribed capital with the company’s own funds, with a shareholding ratio of 100%.
With the acceleration of the construction of digital China, it has become the consensus of local governments to drive the transformation of urban governance by digital transformation. In order to promote the pilot work of digital public infrastructure construction, give full play to the advantages of digital government communication, promote in-depth cooperation in the areas of regional digital public infrastructure management platform, basic capacity building and supporting application verification, build a digital public infrastructure system of regional cities with open sharing, clear boundaries, reliable carriers, sufficient capacity and sufficient reserve, give full play to the advantages of digital government communication in capital, talents, technology and application scenarios, and provide better products and services to customers, so the company plans to build a digital public infrastructure system in Xiong’ an and Xiong’ an.
Total electroacoustic: it is planned to build a production base project of electroacoustic components and electroacoustic components in Yiwu.
It was announced on the evening of December 14th that the company plans to raise funds by means of its own funds, introducing strategic investors to its holding subsidiaries and bank loans. Through its holding subsidiaries, it will invest a total of 1.04 billion yuan in Zhejiang, invest in the project of electroacoustic components and electroacoustic components production base in Yiwu, and build a production line with an annual output of 20 million cars and 14 million mobile phones. In addition, due to the changes in the market environment and other comprehensive reasons, the company decided to terminate the issue of shares to specific targets and apply to Shenzhen Stock Exchange to withdraw the relevant application documents and materials for issuing shares.
Kailitai plans to increase the capital of Shanghai Sailiwei by 5 million yuan to meet the development needs.
() Announcement: In order to meet the company’s future strategic development needs, the company plans to invest in Shanghai Sailiwei Biotechnology Co., Ltd. (referred to as "Shanghai Sailiwei") to increase the capital of Shanghai Sailiwei with its own funds of 5 million yuan, and subscribe for the registered capital of Shanghai Sailiwei of 56,309 yuan. After the capital increase is completed, the company will hold 3.6158% equity of Shanghai Sailiwei. This transaction promotes the company’s industrial operation and capital operation to achieve benign complementarity, and further enhances the company’s overall competitiveness.
Digital Zhengtong plans to spend 20 million yuan to establish a private equity investment partnership.
Digital Zhengtong announced that the company intends to sign the Yichang Huayi Venture Capital Fund Partnership (Limited Partnership) Partnership Agreement with Zhenjiang Fucang Investment Partnership ("Zhenjiang Fucang"), Yichang Investment Holding Group Co., Ltd. ("Yichang Investment") and Huayi Zhimei Investment Management Co., Ltd. ("Huayi Zhimei"). According to the agreement, the four parties will jointly contribute to the establishment of Yichang Huayi Venture Capital Fund Partnership (Limited Partnership). The total investment subscribed by the partnership is RMB 200,000,000.00 Yuan, all in cash. Among them, Beijing Digital Zhengtong Technology Co., Ltd. plans to invest 20 million yuan as a limited partner, Zhenjiang Fucang Investment Partnership (Limited Partnership) plans to invest 98 million yuan as a limited partner, Yichang Investment Holding Group Co., Ltd. plans to invest 80 million yuan as a limited partner and Huayi Zhimei Investment Management Co., Ltd. plans to invest 2 million yuan as a general partner.
It is reported that the partnership will make full use of the investment management advantages of professional investment institutions and the capital, market and technology advantages of listed companies by investing in equity and quasi-equity permitted by applicable laws and business scope in enterprises in China, and actively make industrial layout in emerging scientific and technological fields such as digital economy, new materials and new energy, so as to help listed companies continuously optimize their business structure, extend their industrial chains, cultivate new products and businesses and improve asset quality.
Digital video was reduced by the actual controller Zheng Haitao by 17.26 million shares.
() Announcement: Zheng Haitao, the controlling shareholder and actual controller of the company, reduced the company’s shares by 17.26 million shares from October 27th, 2022 to December 13th, 2023, with a reduction ratio of 1.21%.
Jianke shares plan to spend 30 million to 60 million yuan to buy back shares.
Jianke shares announced that the company intends to use part of the over-raised funds to buy back the company’s shares in a centralized bidding transaction, which will be used to implement equity incentives or employee stock ownership plans. The total amount of repurchase funds is not less than 30 million yuan, not more than 60 million yuan, and the repurchase price is not more than 28 yuan/share.
Financial Street: 21 Jinjie 07 will pay interest on December 18th.
On December 14th, Financial Street Holding Co., Ltd. announced the interest payment, and will pay the interest from December 16th, 2022 to December 15th, 2023 on December 18th, 2023.
According to the interest payment plan, the coupon rate of the first bond variety "21 Jinjie 07" in this period is 3.70%, and the interest paid this time is RMB 37.00 (including tax) per lot (face value of RMB 1,000). After tax deduction, the actual interest paid by individuals and bondholders of securities investment funds is 29.60 yuan; The actual interest paid by non-resident enterprises (including QFII and RQFII) is 37.00 yuan.
Aikang Technology plans to build a 4.6GW HJT battery production project.
Aikang Technology announced that up to now, the company’s HJT components in hand are about 2.95GW, and the company’s own production capacity of HJT batteries cannot meet the order demand. According to the company’s strategic plan, Ganzhou Aikang Optoelectronic Technology Co., Ltd., a wholly-owned grandson company, plans to invest in the construction of a 4.6GW HJT battery production project, with a total investment of 2.1 billion yuan in fixed assets (except the main equipment, the investment in fixed assets such as land, civil engineering and electromechanical facilities has been completed), and a new 600MW and five 800MW HJT battery production lines will be built. This production plan is to expand production by sales. Combining with the market and customer demand forecast and the on-hand orders, the production capacity will be increased by order in batches and line by line, and the completion time will be consistent with the increase of orders in the market. The company plans to complete the entry of the main equipment of the first HJT battery production line in January 2024.
Chuanheng shares: the company and its holding subsidiaries received 3 patent certificates.
On the evening of December 14th, () announced that the company and its holding subsidiary, Guizhou Fulin Mining Co., Ltd., had recently received three patent certificates issued by China National Intellectual Property Administration of the People’s Republic of China, with the patent names: gypsum retarder, highly stable semi-hydrated gypsum and methods for inhibiting the transformation of semi-hydrated gypsum; A collector for synchronously collecting siliceous and magnesia minerals, and a preparation method and application thereof; A paste filling test system. The acquisition of the above patents is conducive to further improving the company’s intellectual property protection system, forming a continuous innovation mechanism, maintaining a leading position in technology, and continuously improving the company’s core competitiveness.
Guangxin materials: wholly-owned subsidiaries change their registered capital and complete the registration of industrial and commercial changes.
On the evening of December 14th, () announced that recently, Jiangxi Guangzhen Photosensitive Materials Co., Ltd. (Jiangxi Guangzhen), a wholly-owned subsidiary of the company, had completed the registration and filing procedures for relevant industrial and commercial changes, and obtained a new Business License issued by Longnan Administrative Examination and Approval Bureau. The registered capital after the change was 105,984,97859 yuan.
On November 24th, 2023, the Company held the 31st meeting of the 4th Board of Directors and the 28th meeting of the 4th Board of Supervisors, deliberated and passed the Proposal on Using Raised Funds to Increase the Capital of a wholly-owned subsidiary and agreed to use the raised funds of 95,984,978.59 yuan to increase the capital of Guangzhen, Jiangxi Province to implement the fundraising project, and all the relevant funds were included in the registered capital. The capital increase was used for the implementation of the fundraising project "Project with an annual output of 50,000 tons of electronic photosensitive materials and supporting materials". After the completion of the capital increase, the registered capital of Jiangxi Guangzhen increased from 10 million yuan to 105,984,859 yuan, and the company still holds 100% of its equity.
Wang Zhaohua, director of Jingquanhua, completed the reduction and reduced his holdings by a total of 2,046,400 shares.
() Announcement: Wang Zhaohua, the company’s shareholder and director, has completed the plan to reduce shares, with a total reduction of 2,046,400 shares, accounting for 0.7501% of the company’s total share capital.
(): The holding subsidiary received the Certificate of High-tech Enterprise.
On the evening of December 14th, Wantong Technology announced that Anhui Henkel Information Technology Co., Ltd. (hereinafter referred to as Henkel Information), a holding subsidiary of the company, received the High-tech Enterprise Certificate jointly issued by Anhui Science and Technology Department, Anhui Finance Department and State Taxation Administration of The People’s Republic of China Anhui Taxation Bureau on December 14th, 2023. The certificate number is: CR202334000619, the issuing date is October 16, 2023, and the validity period is three years.
According to the relevant regulations, Henkel Information can enjoy the relevant preferential policies of the state on high-tech enterprises for three consecutive years (2023, 2024 and 2025) and pay enterprise income tax at the rate of 15%. This preferential tax policy does not affect the financial data of the company’s previously released operating performance.
ShenShenfang A: The sale of commercial land by Great Wall Company, a holding subsidiary, was terminated.
On the evening of December 14, Shenfang A announced that the company held the third meeting of the eighth board of directors on July 28, 2023, and reviewed and approved the Proposal on Selling Commercial Land by Great Wall Company, a holding subsidiary. The board of directors of the company agrees that the holding subsidiary Great Wall Estate Company, Inc. (hereinafter referred to as Great Wall Company) will transfer the commercial land with the plot number of 5408-024-007 located in 774N Broadway, Los Angeles, California90012, the United States to VolteraPower, LLC (hereinafter referred to as the "buyer") for US$ 8.245 million.
On December 12, 2023, the company received the termination notice sent by the buyer on December 11, 2023 Pacific Time. The main contents of the notice are: the buyer has chosen to terminate the agreement according to the transaction agreement, which will take effect on Monday, December 11, 2023.
Qiaoyin Co., Ltd.: A comprehensive project of urban expressway cleaning, ice and snow removal and facility cleaning with a pre-bid of about 82.05 million yuan.
On the evening of December 14th, Qiaoyin Co., Ltd. announced that recently, the company won the bid for the 2024 "Comprehensive Project of Urban Expressway Cleaning, Snow and Ice Removal and Facility Cleaning".
The winning bid amount is 27,350,200.00 yuan/year; The service time is three years from the effective date of signing the contract. (The service period is 3 years, and the contract is signed once a year, and it will be signed year by year on the premise that the financial budget is guaranteed and the annual assessment is qualified); It is estimated that the total bid amount is 82,050,600.00 yuan /3 years.
Honglu Steel Structure: The wholly-owned subsidiary received a government subsidy of 13.5 million yuan.
On the evening of December 14th, () announced that recently, Hubei Honglu Steel Structure Co., Ltd., a wholly-owned subsidiary of the company, received a government subsidy of 13.5 million yuan, and the subsidy was received on December 14th, 2023. The company’s total profit in 2023 will increase by 13.5 million yuan when it receives the government subsidy. The specific amount of influence and related accounting treatment shall be subject to the results confirmed by the audit institution’s annual audit. Investors are invited to pay attention to investment risks.
Financial Street: 21 Jinjie 06 will pay interest on December 18th.
On December 14th, Financial Street Holding Co., Ltd. announced the interest payment, and will pay the interest from December 16th, 2022 to December 15th, 2023 on December 18th, 2023.
According to the interest payment plan, the coupon rate of the first bond variety "21 Jinjie 06" in this period is 3.28%, and the interest paid this time is RMB 32.80 (including tax) per lot (face value of RMB 1,000). After tax deduction, the actual interest paid by individuals and bondholders of securities investment funds is 26.24 yuan; The actual interest paid by non-resident enterprises (including QFII and RQFII) is 32.80 yuan.
LU ZHOU LAO JIAO CO.,LTD: The controlling shareholder plans to increase the company’s shares by 200 million yuan to 250 million yuan.
() On the evening of December 14th, it was announced that LU ZHOU LAO JIAO CO.,LTD Group, the controlling shareholder of the company, based on its recognition of the company’s long-term investment value and confidence in the company’s sustainable and stable development in the future, planned to increase its holdings of the company’s shares through centralized bidding through its wholly-owned subsidiary, Sichuan Jinduo Investment Co., Ltd., with a planned increase of not less than 200 million yuan and not more than 250 million yuan. The increase plan does not set a price range.
Yalian Development is suspected of violating laws and regulations. The China Securities Regulatory Commission filed a case against the company
Yalian Development announced that the company received the Notice of Filing a Case by China Securities Regulatory Commission issued by China Securities Regulatory Commission, and the China Securities Regulatory Commission decided to file a case against the company because it was suspected of violating laws and regulations in information disclosure.
The manager of Youfu completed the reduction of 2.75% of the shares.
() Announcement: As of December 13, 2023, the company manager has reduced the company’s shares by 27,075,900 shares, accounting for 2.75% of the total share capital. This reduction plan has been implemented.
Gongda Electro-acoustic plans to jointly increase the capital of Gongda Zhejiang by 70 million yuan with Shanghai Xinchen.
A total of electroacoustic announcement, the company and Shanghai Century Xinchen Consulting Management Partnership (Limited Partnership) ("Shanghai Xinchen") intend to increase the capital of the total (Zhejiang) () Co., Ltd. ("Gongda Zhejiang") with their own funds, that is, the company and Shanghai Xinchen respectively subscribed for the newly-increased registered capital of RMB 63 million and RMB 7 million, which will total the registered capital of Zhejiang from the current RMB 30 million.
This capital increase will be used for the production development of Zhejiang, which will help to enhance the market competitiveness and sustainable development of Zhejiang, and also help to promote the steady development of the company’s industrialization layout, which is in line with the company’s development strategy and long-term interests.
Xinhua Chemical, the shareholder of Horizon, has reduced its holdings by 2,353,700 shares.
() Announcement: Changshu Xinhua Chemical Co., Ltd. (hereinafter referred to as "Xinhua Chemical"), the shareholder of the company, has reduced its holdings of 2,353,700 shares in the form of block trading.
Total electroacoustic termination and withdrawal of application documents.
A total of electroacoustic announcements were made. At the 23rd meeting of the 5th Board of Directors and the 23rd meeting of the 5th Board of Supervisors held on December 14th, 2023, the Company reviewed and passed the Proposal on Terminating the Company’s Issuance of Shares to Specific Objects and Withdrawing the Application Documents, the Proposal on Signing the Termination Agreement and Related Transactions with the Subscription Objects with Conditional Effect, and agreed that the Company would terminate the issuance of shares to specific objects ("this offering") and sign with the Subscription Objects.<共达电声股份有限公司与无锡韦感半导体有限公司关于向特定对象发行股票募集资金之附条件生效的股份认购协议>The termination agreement (the "Termination Agreement") and applied to the Shenzhen Stock Exchange (the "Shenzhen Stock Exchange") to withdraw the relevant application documents, and the related directors abstained from voting.
Dongjian Technology plans to increase capital by 100 million yuan to improve its asset-liability structure.
() Announcement, the company plans to increase the capital of Guangdong Dongjian Automobile Intelligent System Co., Ltd. (referred to as "Dongjian Intelligent"), a wholly-owned subsidiary, with its own funds of 100 million yuan. This capital increase can effectively improve the asset-liability structure of Dongjian Intelligent, a wholly-owned subsidiary, and ensure the daily capital flow needs of Dongjian Intelligent.
Lexin Medical: Application for registration certificate of electronic sphygmomanometer medical device was accepted.
() Announcement, the company’s application for registration certificate of electronic sphygmomanometer medical devices has been accepted, and the model is CS-WBP1-C.
The expiration of the shareholding reduction plan of the controlling shareholder of Xiaosong Co., Ltd., an apology and a commitment to buy it back.
() Announcement: Shenzhen Huaxin Chuangli Technology Industrial Development Co., Ltd. ("Huaxin Chuangli"), the controlling shareholder of the company, has reduced its holdings of 1,253,000 shares, accounting for 0.394% of the total share capital, and the period of this reduction plan has expired.
Among the above reductions, Huaxin Chuangli’s reduction of 953,000 shares of the company on September 4, 2023 violated the relevant requirements of the China Securities Regulatory Commission’s "Further Regulating Share Reduction". Huaxin Chuangli has deeply realized the mistake of illegally reducing the company’s shares this time, expressed sincere apologies for this mistake, and made the following commitments: Huaxin Chuangli, the controlling shareholder of the company, promised to buy back 953,000 shares of the company that were illegally reduced as soon as possible within the scope permitted by the rules, and all the proceeds from this share repurchase will be owned by the listed company.
The controlling shareholder of LU ZHOU LAO JIAO CO.,LTD intends to increase its shareholding in the company by 200 million to 250 million yuan.
LU ZHOU LAO JIAO CO.,LTD announced that, based on the recognition of the company’s long-term investment value and confidence in the company’s sustainable and stable development in the future, LU ZHOU LAO JIAO CO.,LTD Group Co., Ltd., the controlling shareholder of the company, plans to increase its shares through centralized bidding within six months from the announcement date through its wholly-owned subsidiary, Sichuan Jinduo Investment Co., Ltd., with a planned increase of not less than 200 million yuan and not more than 250 million yuan. There is no price range for this increase plan.
Gongda Electro-acoustic plans to build a production base project of electro-acoustic components and components in Yiwu.
A total of electroacoustic announcements were made. The company plans to sign a project investment framework agreement with the management committee of Yiwu Economic Development Zone. It plans to raise funds by means of its own funds, introducing strategic investors to its holding subsidiaries and bank loans. Through its holding subsidiaries, it will invest a total of 1.04 billion yuan in Zhejiang, invest in the construction of electroacoustic components and electroacoustic components production base in Yiwu, and build a production line with an annual output of 20 million cars and 14 million mobile phones.
At the same time, the company announced that due to changes in the market environment and other related reasons, after full communication and careful analysis with relevant parties, the company decided to terminate the issue of shares to specific targets and apply to the Shenzhen Stock Exchange to withdraw the relevant application documents for issuing shares.
The controlling shareholder of LU ZHOU LAO JIAO CO.,LTD plans to increase its shareholding by not less than 200 million yuan and not more than 250 million yuan.
LU ZHOU LAO JIAO CO.,LTD announced that LU ZHOU LAO JIAO CO.,LTD Group Co., Ltd. ("Laojiao Group"), the controlling shareholder of the company, plans to increase its shares through centralized bidding within six months from the date of this announcement through Sichuan Jinduo Investment Co., Ltd. ("Jinduo Company"), and the amount to be increased is not less than 200 million yuan and not more than 250 million yuan.
Alleged information disclosure, violation of laws and regulations, Asian Union Development was put on file.
On the evening of December 14, Yalian Development Disclosure announced that the CSRC decided to file a case against the company because of alleged information disclosure violations.
Yalian Development said that during the investigation, the company will actively cooperate with the investigation work of the CSRC and fulfill its information disclosure obligations in a timely manner in strict accordance with the provisions of relevant laws and regulations and regulatory requirements.
The controlling shareholder of Shengxun Co., Ltd. released the pledge of 5,487,900 shares.
() Announcement: Recently, the company received a notice from the controlling shareholder Guangxi Tianfu Investment Co., Ltd. ("Tianfu Investment"), and learned that its 5,487,900 shares (accounting for 6.71% of the company’s total share capital) were released from pledge.
Beixin Road and Bridge: The construction and installation fee for the EPC project jointly won the bid is about 370 million yuan.
() On the evening of December 14th, it was announced that the consortium composed of the company (the leader of the consortium) and China Huaxi Engineering Design and Construction Co., Ltd. was determined as the winning bidder for the general contract of survey, design and construction of the reconstruction project from Jizhou to Gongshan section of G244 Nanjiang County. Because the project is an EPC project, the downward floating rate of the winning bid is 3.66%; The company is responsible for the construction part of the project, and the construction and installation fee is about 370 million yuan. The project duration is 730 days.
Beixin Road and Bridge Consortium won the bid for the general contracting project of highway reconstruction project.
Beixin Luqiao announced that the company recently received the Notice of Winning Bid from Sichuan Nanjiang Traffic Construction Investment Co., Ltd. According to the Letter of Acceptance, the consortium formed by the company (the leader of the consortium) and China Huaxi Engineering Design and Construction Co., Ltd. was determined as the winning bidder for the general contract of survey, design and construction of the reconstruction project from Jizhou to Gongshan in Nanjiang County ("the project"). Because the project is an EPC project, the downward floating rate of the winning bid is 3.66%; The company is responsible for the construction part of the project, and the construction and installation fee is about 370 million yuan.
The total length of the route of the project is 5.26 kilometers, including 2.76 kilometers for new construction and 2.5 kilometers for reconstruction. The whole line adopts the technical standard of two-way four-lane first-class highway, with a design speed of 60km/h and a roadbed width of 20m, and the bridge is the same width as the roadbed.
* The application for the increase of ST refining stone was approved by China Securities Regulatory Commission for registration.
() Announcement: On December 14, 2023, the company received the Reply of China Securities Regulatory Commission on Approving the Registration of Refining Stone Aviation Technology Co., Ltd. to Issue Shares to Specific Objects (No.2800 [2023] of the CSRC), and the reply is as follows:
1. Agree to the company’s application for registration of issuing shares to specific targets. II. This issuance of the company shall be implemented in strict accordance with the application documents and issuance plan submitted to Shenzhen Stock Exchange. Three, this reply is valid for 12 months from the date of consent to registration. Four, from the date of registration to the end of this issue, if the company has major events, it shall promptly report to the Shenzhen Stock Exchange and deal with them according to relevant regulations.
ST Hongda: The CSRC decided to file a case against the company’s actual controller for allegedly violating the regulations.
() On the evening of December 14th, it was announced that Zhou Yifeng, the actual controller of the company, had received a notice of filing a case issued by the China Securities Regulatory Commission, and the China Securities Regulatory Commission decided to file a case for him because he was suspected of violating laws and regulations in information disclosure.
Beixin Road and Bridge: the consortium won the bid for EPC project.
Beixin Luqiao announced that it recently received the Notice of Winning Bid from Sichuan Nanjiang Traffic Construction Investment Co., Ltd. According to the Letter of Acceptance, the consortium composed of the company (the leader of the consortium) and China Huaxi Engineering Design and Construction Co., Ltd. was determined as the winning bidder for the general contract of survey, design and construction of the reconstruction project from Jizhou to Gongshan in Nanjiang County. Because the project is an EPC project, the downward floating rate of the winning bid is 3.66%; Our company is responsible for the construction part of the project, and the construction and installation fee is about 370 million yuan.
Luolai Life: Use 28 million yuan of idle raised funds to buy wealth management products.
On the evening of December 14th, () announced that on December 14th, 2023, the company used 28 million yuan of idle raised funds to purchase wealth management products. The relevant information about this purchase of wealth management products is that the signing party is Industrial and Commercial Bank of China, the product name is corporate structured deposit, and the product type is guaranteed capital and fixed income. The purchase amount is 28 million yuan, and the expected annualized rate of return is 1.45%. The value date is December 14, 2023, and the maturity date is irregular.
Total electroacoustic: The Board of Directors and the Board of Supervisors deliberated and passed the Proposal on Signing an Investment Framework Agreement between the Company and the Management Committee of Yiwu Economic Development Zone.
On the evening of December 14th, Gongda Electro-acoustic announced that in order to further implement the company’s development strategy, implement the overall development layout plan, and promote the rapid and healthy development of its holding subsidiary, Gongda (Zhejiang) Electro-acoustic Co., Ltd. (hereinafter referred to as "Gongda Zhejiang"), the company intends to sign the Investment Framework Agreement for Electro-acoustic Components and Electro-acoustic Components Production Base Project with the Management Committee of Yiwu Economic Development Zone. With its own funds, the company plans to raise funds by introducing strategic investors and bank loans to its holding subsidiaries. Through a total investment of 1.04 billion yuan in Zhejiang (including 700 million yuan in fixed assets and 340 million yuan in working capital), it will invest in the construction of electroacoustic components and electroacoustic components production base in Yiwu, and build an electroacoustic components and electroacoustic components production line with an annual output of 20 million cars and 14 million mobile phones.
On December 14th, 2023, the company held the 23rd meeting of the 5th Board of Directors and the 23rd meeting of the 5th Board of Supervisors, and deliberated and passed the Proposal on Signing the Investment Framework Agreement between the Company and the Management Committee of Yiwu Economic Development Zone and the Proposal on Requesting the General Meeting of Shareholders to authorize the Board of Directors to handle matters related to the investment of electroacoustic components and electroacoustic component production base projects. These proposals still need to be submitted to the General Meeting of Shareholders for deliberation. After being reviewed and approved by the shareholders’ meeting, the company will formally sign the Investment Framework Agreement for Electroacoustic Components and Electroacoustic Components Production Base Project with the Management Committee of Yiwu Economic Development Zone.
Kehua Bio: The largest shareholder of the company will probably change.
() On the evening of December 14th, it was announced that Zhuhai Baolian Investment Holding Co., Ltd., the largest shareholder, intends to transfer 5% of the shares of the company by public solicitation of the transferee, and the transfer price is not lower than 20 yuan/share (inclusive). At the same time, it is planned to entrust the voting rights corresponding to 10.64% of the shares of the company to the transferee free of charge. If the transfer of public solicitation and the entrustment of voting rights are completed, the largest shareholder of the company may change.
ST Hongda’s actual controller received the notice of filing a case from China Securities Regulatory Commission.
ST Hongda announced that the company received a notice from Zhou Yifeng, the actual controller of the company, on December 14, 2023, and learned that it received the Notice of Filing a Case (No.:CSRC Filing Word No.0102023024) issued by China Securities Regulatory Commission ("China Securities Regulatory Commission") on December 14, 2023. Because of its alleged violation of information disclosure, according to the People’s Republic of China (PRC) Securities Law and the People’s Republic of China,
This investigation is aimed at Zhou Yifeng. During the investigation, Zhou Yifeng will actively cooperate with the relevant work of the China Securities Regulatory Commission and fulfill his information disclosure obligations in strict accordance with relevant laws, regulations and regulatory requirements.
Kehua Bio: Zhuhai Baolian, the largest shareholder, plans to transfer 5% of its shares in the company by agreement.
Kehua Bio announced that Zhuhai Baolian, the largest shareholder, intends to transfer its 5% shares of the company through public solicitation of the transferee at a price not lower than RMB 20 yuan/share (inclusive), and at the same time, it intends to entrust the voting rights corresponding to its 10.64% shares of the company to the transferee free of charge.
Jiamei Packaging: Chen Min was elected as the chairman.
On the evening of December 14th, () announced that the first meeting of the third board of directors of the company was held in the company conference room on December 14th, 2023 by means of on-site communication, and the Proposal on Electing the Chairman of the Third Board of Directors of the company was reviewed and passed. The members of the third board of directors of the company unanimously agreed to elect Mr. Chen Min as the chairman of the third board of directors of the company.
Zhejiang Zhenyuan: The deviation of the closing price increase for two consecutive trading days has exceeded 20%.
On the evening of December 14th, () announced that the deviation of the closing price increase of the company’s shares for two consecutive trading days on December 13th and 14th, 2023 was more than 20%. According to the relevant provisions of the Trading Rules of Shenzhen Stock Exchange, the company’s stock trading was an abnormal fluctuation. After verification, there is no need to correct or supplement the information disclosed by the company in the early stage; The company has not found that the public media has recently reported undisclosed major information that may or has had a great impact on the company’s stock trading price; There have been no major changes in the company’s production and operation situation and internal and external operating environment recently; The company, the controlling shareholder and the actual controller have no major matters that should be disclosed but not disclosed, or major matters in the planning stage; Upon inquiry, the controlling shareholder and actual controller of the company did not buy or sell the company’s stock during the abnormal fluctuation of the stock.
Xinhe shares: complete the industrial and commercial change registration and renew the business license.
On the evening of December 14th, () announced that up to now, the company has completed the industrial and commercial change registration procedures and obtained the Business License renewed by Xiamen Municipal Market Supervision Administration. The registered capital is changed to RMB four hundred and thirty-nine thousand six hundred and ninety-eight Yuan only.
The Company held the 29th meeting of the 4th Board of Directors on April 27th, 2023, and the 2022 Annual General Meeting of Shareholders on May 22nd, 2023, and reviewed and approved the Proposal on Unfulfilled Conditions for Lifting the Restricted Stock Incentives in the Second Period of 2021 and Repurchase and Cancellation of Some Restricted Stocks, and the Proposal on Changing the Company’s Registered Capital and Revision.<公司章程>Proposal on some clauses, decided to repurchase and cancel 1,519,287 restricted shares held by the incentive object of the company’s restricted stock incentive plan in 2021, which have been granted but not yet unlocked.
Jingui Banking: Major asset restructuring will be held on December 21st.
() Announcement, the company intends to issue shares to Hunan Nonferrous Industry Investment Group Co., Ltd. ("Nonferrous Group") and () Group Co., Ltd. to purchase 100% equity of Hunan Baoshan Nonferrous Metals Mining Co., Ltd. held by them in total, and at the same time, it plans to issue shares to Nonferrous Group to raise matching funds ("this reorganization"). This reorganization constitutes a related party transaction and a major asset reorganization.
According to the Announcement of the 14th Review Meeting of M&A Review Committee of Shenzhen Stock Exchange in 2023, the M&A Review Committee of Shenzhen Stock Exchange is scheduled to hold the 14th Review Meeting of M&A Review Committee in 2023 on December 21st, 2023 to review the company’s application for this restructuring.
Hongbo shares: Century Securities appointed Gu Junyi to replace Nie Ronghua as the sponsor representative of the company’s continuous supervision.
On the evening of December 14th, () announced that the company had recently received a letter from the sponsor institution Century Securities Co., Ltd. (hereinafter referred to as "Century Securities") on replacing the sponsor representative for continuous supervision. Century Securities, as the continuous supervision organization of the company’s non-public offering of shares in 2016, was originally appointed by Mr. Chen Qing and Mr. Nie Ronghua. Now, due to the change of Mr Nie Ronghua’s personal work, he is no longer responsible for the continuous supervision of the company. In order to ensure the orderly progress of the company’s continuous supervision, Century Securities appointed Mr. Gu Junyi to replace Mr. Nie Ronghua as the sponsor representative of the company’s continuous supervision and continued to perform relevant duties.
Dongjian Technology: It is planned to increase the capital of Dongjian Intelligent, a wholly-owned subsidiary, by 100 million yuan.
On the evening of December 14th, Dongjian Technology announced that the company held the fifth meeting of the third board of directors and the fifth meeting of the third board of supervisors on December 14th, 2023, respectively, and reviewed and approved the Proposal on Capital Increase of Guangdong Dongjian Automobile Intelligent System Co., Ltd. (referred to as "Dongjian Intelligent"), agreeing that the company would increase its capital of Guangdong Dongjian Automobile Intelligent System Co., Ltd. with its own funds of RMB 100 million, which does not constitute a connected transaction. This matter is within the approval authority of the board of directors and does not need to be submitted to the shareholders’ meeting for consideration.
Jin Hyundai: "Cash Convertible Bonds" will be listed and traded on December 19th.
() It is announced that the company’s 203 million yuan convertible corporate bonds will be listed and traded in Shenzhen Stock Exchange from December 19, 2023, with the bond code "123232" for short.
(): Received the Decision on Administrative Punishment from China Securities Regulatory Commission.
Hublot announced on the evening of December 14th that the company received the "Decision on Administrative Punishment" issued by China Securities Regulatory Commission that day. The company is suspected of violating laws and regulations in information disclosure. Without fully evaluating and carefully understanding the essence of private network communication business, it will confirm the operating income and operating cost of the business according to the amount incurred in sales and procurement contracts, which constitutes a false increase in operating income, resulting in false records in the annual report from 2017 to 2020 disclosed by the company. The China Securities Regulatory Commission decided to order the company to make corrections, give a warning and impose a fine of 5 million yuan; Qian Jing, the current chairman of Hengbao, was given a warning and fined 2 million yuan; Xu Xiaoling, then director, and Sister Chen, then secretary of the board of directors, were given warnings and fined 500,000 yuan respectively.
The price of international composite materials is determined to be 2.66 yuan/share, and the price-earnings ratio is lower than that of the same industry.
Chongqing International Composite Materials Co., Ltd. (hereinafter referred to as "()"), a glass fiber head enterprise, published an announcement on the evening of December 13th. The number of shares publicly issued this time was 700 million shares, and the issue price was 2.66 yuan/share. On December 15, 2023, online and offline subscriptions were made. The subscription is called international composite materials for short, and the subscription code is 301526.
In this IPO, International Composite Materials plans to publicly issue 700 million shares and raise 2.481 billion yuan. The funds raised are planned to be used for the intelligent manufacturing production line project of ECT glass fiber with an annual output of 150,000 tons, the technical renovation project of cold repair of high-performance glass fiber production line with an annual output of 150,000 tons in F10B, the technical renovation project of upgrading high-performance electronic-grade glass fiber products and supplementary working capital.
In recent years, the performance of international composite materials has increased significantly-from 2020 to 2022, the company’s operating income was 6.912 billion yuan, 8.300 billion yuan and 7.894 billion yuan respectively, with a compound annual growth rate of 6.87%; After deducting non-profits, the net profits returned to the mother were 240 million yuan, 1.083 billion yuan and 983 million yuan respectively, with an average compound annual growth rate of 102.51%.
International Composite Materials is a high-tech enterprise engaged in R&D, production and sales of glass fiber and its products. It has mastered the whole process technology of glass fiber production and has obvious competitive advantages in the industry. The company is widely used in the fields of wind turbine blades, engineering plastics and electronics. The company plans to improve the supply chain, strengthen the production chain, extend the product chain and actively expand into the field of new composite materials.
At the issue price of 2.66 yuan/share this time, the diluted P/E ratio of the company’s net profit before and after deduction in 2022 is 10.21 times, which is lower than the static average P/E ratio of the same industry in the latest month published by the China Securities Index, and also lower than the average static P/E ratio of the listed companies in the same industry before and after deduction in 2022, which is 10.24 times.
The stock issuance of international composite materials adopts a combination of targeted placement, offline issuance and online issuance to investors participating in strategic placement. Among them, the initial strategic placement of 210 million shares, accounting for 30% of the number of shares issued. Seven investors including Chongqing Yufu Capital Operation Group, Cinda Innovation Investment and Yunnan Jiaotou Private Equity Investment Fund will participate in the placement.
ST Modern was once again investigated by the CSRC.
On the evening of December 13th, () announced that the China Securities Regulatory Commission had decided to file a case against the company according to the Securities Law of People’s Republic of China (PRC), the Administrative Punishment Law of the People’s Republic of China and other laws and regulations because the company was suspected of violating laws and regulations on information disclosure. During the investigation, the company will actively cooperate with the work of the China Securities Regulatory Commission and fulfill its information disclosure obligations in strict accordance with regulations. However, in the announcement, ST Modern did not disclose the specific reasons for the company’s alleged violation of information disclosure.
The "Economic Information Daily" reporter noted that this is the second time that ST Modern has been investigated by the Securities and Futures Commission this year. In June this year, ST Modern issued a notice about receiving the notice of filing a case from the China Securities Regulatory Commission. The reason was that the company failed to disclose the 2022 annual report within the statutory time limit. According to the Securities Law of People’s Republic of China (PRC), the Administrative Punishment Law of the People’s Republic of China and other laws and regulations, the China Securities Regulatory Commission decided to file a case for the company.
According to public information, ST Modern is a global fashion brand operator, whose main business focuses on clothing bags, skin care and beauty, jewelry accessories and other fields. At present, the main income components of ST Modern are clothing and accessories (own brand), clothing and accessories (agent brand) and perfumed products.
The data shows that from 2020 to 2022 and from January to September in 2023, the total operating income of ST Modern was 512 million yuan, 385 million yuan, 230 million yuan and 215 million yuan respectively, of which 2021 and 2022 decreased by 24.75% and 40.32% respectively. The net profit returned to the mother was 7,319,500 yuan,-39,483,200 yuan,-41,401,200 yuan and-55,151,100 yuan respectively, which were negative for many years. The net cash flows from operating activities were-172 million yuan, 163 million yuan, 3,784,800 yuan and 17,796,300 yuan respectively.
*ST stone refining: the application for issuing shares to specific objects was approved by China Securities Regulatory Commission for registration.
On the evening of December 14th, *ST lianshi announced that on December 14th, 2023, the company received the "Reply on Agreeing to the Registration of Lianshi Aviation Technology Co., Ltd. to Issue Shares to Specific Objects" issued by China Securities Regulatory Commission (ZJK [2023] No.2800), and agreed to the company’s application for registration of issuing shares to specific objects.
Aoyang Health: The controlling shareholder Aoyang Group pledged 15 million shares of the company.
On the evening of December 14th, () announced that the company had recently received a notice from the controlling shareholder Aoyang Group Co., Ltd. (hereinafter referred to as "Aoyang Group") and learned that Aoyang Group had pledged some shares of the company.
On December 13th, 2023, Aoyang Group pledged its 15,000,000 shares with Mr. Wu Jianyong. The pledged shares accounted for 6.37% of the shares held by Aoyang Group and 1.96% of the company’s total share capital.
Shengxun shares: Tianfu Investment, the controlling shareholder, released 5,487,900 shares this time.
On the evening of December 14th, Shengxun announced that the company had recently received a notice from Guangxi Tianfu Investment Co., Ltd. (hereinafter referred to as "Tianfu Investment"), and learned that some of its shares were pledged. The details are as follows: Tianfu Investment released 5,487,900 shares this time, and the pledge release date was December 13th, 2023.
Beixin Road and Bridge: The company recently received the Notice of Winning Bid.
On the evening of December 14th, Beixin Road and Bridge announced that the company had recently received the Notice of Winning Bid from Sichuan Nanjiang Traffic Construction Investment Co., Ltd.. According to the Letter of Acceptance, the consortium formed by the company (the leader of the consortium) and China Huaxi Engineering Design and Construction Co., Ltd. was determined as the winning bidder for the general contract of survey, design and construction of the reconstruction project from Jizhou to Gongshan in Nanjiang County (hereinafter referred to as "the project"). Because the project is an EPC project, the downward floating rate of the winning bid is 3.66%; The company is responsible for the construction part of the project, and the construction and installation fee is about 370000000.00 yuan.
Jianke shares: it is planned to buy back the shares of the company at a price of 30 million yuan to 60 million yuan.
On the evening of December 14th, Jianke Co., Ltd. announced that the company intends to use part of the over-raised funds to buy back the company’s shares by centralized bidding. The total amount of repurchase funds is not less than 30 million yuan (inclusive) and not more than 60 million yuan (inclusive). The specific total amount of repurchase funds is subject to the total amount of funds actually used to buy back shares at the expiration of the repurchase period.
ST Hongda: The actual controller received the notice of filing a case from China Securities Regulatory Commission.
ST Hongda announced that on December 14, 2023, the company received a notice from Zhou Yifeng, the actual controller of the company, and learned that it received the Notice of Filing a Case issued by the China Securities Regulatory Commission on December 14, 2023. On December 14, 2023, the China Securities Regulatory Commission decided to file a case against it because it was suspected of illegal information disclosure.
Guibao Technology plans to invest in silicone’s advanced materials research and development and industrialization project.
() Announcement, the company plans to invest RMB 150 million in Shanghai to set up Sibao Technology (Shanghai) Co., Ltd. (subject to the final registration by the competent authority) to build advanced materials research and development and industrialization projects in silicone; Make full use of Shanghai’s international advantages, attract high-end talents and solve the technical problems of high-end materials in silicone industry.
Huaxin Chuangli, the controlling shareholder of Xiaosong Co., Ltd., was ordered to take corrective regulatory measures for illegal reduction.
Xiaosong Co., Ltd. issued an announcement, and Shenzhen Huaxin Chuangli Technology Industrial Development Co., Ltd. ("Huaxin Chuangli"), the controlling shareholder of the company, received the Decision on Taking Corrective Measures against Shenzhen Huaxin Chuangli Technology Industrial Development Co., Ltd. issued by Guangdong Supervision Bureau of China Securities Regulatory Commission on December 14, 2023. The details are as follows:
Recently, Huaxin Chuangli reduced its holdings of 953,000 shares of Guangdong Xiaosong Technology Co., Ltd. through centralized bidding, which violated the provisions of Item (3) of Article 6 of Several Provisions on Shareholder and Dong Jiangao of Listed Companies (Announcement [2017] No.9 of CSRC). According to the relevant provisions of Article 14 of the Provisions on Shareholder and Dong Jiangao of Listed Companies to Reduce their Shares, Guangdong Securities Regulatory Bureau decided to take regulatory measures to order Huaxin Chuangli to make corrections.
A total of 1.04 billion yuan will be invested to build a production base of electroacoustic components and components in Yiwu.
It was announced on the evening of December 14th that the company plans to raise funds by means of its own funds, introducing strategic investors to its holding subsidiaries and bank loans, and invest a total of 1.04 billion yuan in Zhejiang through its holding subsidiaries to invest in the production base project of electroacoustic components and electroacoustic components in Yiwu. In addition, due to the changes in the market environment and other comprehensive reasons, the company decided to terminate the issue of shares to specific targets and apply to Shenzhen Stock Exchange to withdraw the relevant application documents and materials for issuing shares.
Gongda electroacoustic is located in Weifang, Shandong Province, with a strong local acoustic foundation. The company is also a professional manufacturer and service provider of micro electro-acoustic components and electro-acoustic components, and an electro-acoustic technology solution provider. Its main business is research and development, production and sales of micro electro-acoustic components and electro-acoustic components. Its main products include MEMS acoustic sensors, electret acoustic sensors (ECM), car voice modules, RNC vibration sensor modules, micro speakers/receivers and their array modules. The company’s products are widely used in smart phones, smart wear, smart homes, automotive electronics, Internet of Things and other fields.
Let’s first look at the latest investment layout of Gongda Electro-acoustic in Ningbo.
A total of 1.04 billion yuan (including 700 million yuan in fixed assets and 340 million yuan in working capital) will be invested in the construction of electroacoustic components and electroacoustic components production base in Yiwu, and the production line of electroacoustic components and electroacoustic components with an annual output of 20 million cars and 14 million mobile phones will be built.
The above matters have been reviewed and approved by the board of directors of the company and still need to be submitted to the shareholders’ meeting of the company for consideration.
The planned land area of the production base project is about 50 mu, and it is expected to be put into production within 18 months from the date of signing the contract for the assignment of the right to use state-owned construction land, with an annual output value of 1 billion yuan and an annual tax payment of 60 million yuan.
Gongda Electro-acoustic said that the investment in this project will help to realize the integrated layout of the company’s horizontal expansion and meet the company’s strategic development requirements. After the completion of this project, it will further promote the layout of the company’s parallel industries, expand the company’s business scale and help improve the company’s future business performance.
Let’s look at the termination of the fixed increase. On the evening of November 22 last year, Gongda Diansheng announced that it intends to issue no more than 51.3875 million shares to Wuxi Weigan, the controlling shareholder, and the total amount of funds to be raised does not exceed 500 million yuan. At that time, due to the good development opportunities of downstream industries, a total of electroacoustic plans to expand production and upgrade around the original main business through fixed-income projects.
According to the announcement disclosed at that time, a total of electroacoustic raised funds were mainly used for investment and construction of smart car module upgrading and expansion projects, MEMS sensor and module upgrading and expansion projects, high-end speaker and module upgrading projects, as well as supplementary liquidity and repayment of bank loans. The funds to be used were 150 million yuan, 185 million yuan, 55 million yuan and 110 million yuan respectively.
It is estimated that after all the electro-acoustic projects are put into production, the production capacity of the company’s in-vehicle acoustic products, MEMS sensors and high-end micro-speakers will be effectively increased, and the optimized layout of products and the category expansion of in-vehicle business will be realized, which will help to achieve scale effect, rapidly increase market share and help the company become a world-class overall solution provider of electro-acoustic technology.
For terminating this issuance and withdrawing the application documents, the reasons given by electroacoustic are related reasons such as changes in the market environment.
Dongfang Tong intends to sell 100% equity of Taice Technology and withdraw from smart emergency business.
() Announcement, the company intends to transfer 100% equity of Beijing Taice Technology Co., Ltd. ("Taice Technology") and withdraw from the smart emergency business with weak synergy with the company’s basic software and network information security main business. The transaction price is 400 million yuan (including: the transfer price of 100% equity of the target company is 370 million yuan, and the payment paid by the transferee to the company to repay the loan debt is 30 million yuan). After the transaction is completed, the company will no longer hold the equity of Taice Technology, and Taice Technology and its wholly-owned subsidiaries, Dongfang Tong Innovation Technology (Chongqing) Co., Ltd. and TESTOR SINGAPORE PTE.LTD, will no longer be included in the consolidated statements of the company.
The announcement shows that Taice Technology’s main business is smart emergency, and its main directions are urban safety, emergency communication and safe production. Affected by multiple factors, such as domestic and international environment, macro-economy and industry cycle, the fluctuation of construction cycle and government budget led to great fluctuations in Taice’s technology business volume and income, and the overall situation was less than expected. The collaborative interaction between smart emergency business and the company in terms of resource collaboration and profit contribution is also decreasing year by year. The company intends to withdraw from the smart emergency business with weak synergy with the main business of basic software and network information security to eliminate the uncertain impact of this business on the company’s performance. In the future, we will focus on traditional main businesses with strong profitability, such as basic software and information security, and improve the overall operational efficiency of the company.
Amperon will be listed on the Growth Enterprise Market on December 18th.
() Announcement, the company’s stock will be listed on the Growth Enterprise Market of Shenzhen Stock Exchange on December 18th, 2023.
High-tech development two Sun companies jointly won the bid for the county-level smart cloud brain platform (Phase I) project.
() Announcement, the consortium formed by the company’s controlling Sun Company, Sichuan Beizhi Digital Energy Information Engineering Co., Ltd. (the leader of the consortium, referred to as Beizhi Digital Energy Technology Co., Ltd.), the company’s wholly-owned Sun Company, and Shanghai Urban Construction Design and Research Institute (Group) Co., Ltd. (the member of the consortium, referred to as Shanghai Urban Construction ()) won the bid for the "District and County Smart Cloud Brain Platform (Phase I) project. Recently, the consortium and the purchaser Chengdu Gaoxin Vision Digital Technology Co., Ltd. (referred to as Gaoxin Vision for short) formally signed the Project Contract of Chengdu Gaoxin Vision Digital Technology Co., Ltd. District-level Smart Cloud Brain Platform (Phase I), with a tentative total contract amount of 215 million yuan, of which the company Sun Company’s Bizhi Digital Energy and Bite Digital Division will undertake the work of this project totaling 214 million yuan.
According to the announcement, if the project can be successfully implemented as planned and completed, it is estimated that the business income will be about 87 million yuan in 2023 (after deducting the impact of taxes), of which about 17 million yuan can be confirmed by Bizhi Digital and 70 million yuan can be confirmed by Bite Digital.
Deep-water Haina won the bid for the EOD project integrating comprehensive demonstration management and green industry development in Hutubi River Basin of Changji Prefecture.
() Announcement, the company received the Notice of Winning Bid from Hutubi County Branch of Changji Ecological Environment Bureau. The company is the winning bidder (the winning social capital party) of the EOD project integrating comprehensive demonstration management and green industry development in Hutubi River Basin of Changji Prefecture. The Company and the People’s Government of Hutubi County, Xinjiang intend to sign the EOD Project Contract for Integrated Ecological Demonstration and Green Industry Development in Hutubi River Basin of Changji Prefecture.
The project is divided into short-term and long-term plans to be implemented respectively. The short-term plan includes the sub-project of the comprehensive improvement project of water ecological environment in Hutubi River basin-"Ecological restoration and comprehensive environmental improvement of sand pits left over from history" and the intelligent factory land-based breeding demonstration project in Hutubi County, whose planning and design have been completed and have been declared to be included in the national EOD demonstration library. The long-term plan includes the sub-project of the comprehensive improvement project of the water ecological environment in Hutubi River Basin-"Hutubi River (the first section of Xiaba-Qingnian Canal) floodplain improvement project", Tianhu Wetland project in Hutubi County, and organic pasture carbon fixation planting and processing project in Hutubi County. The total investment of the project is estimated to be 264 million yuan in the near future, and the cooperation period of the project is 30 years.
Gree real estate intends to transfer 5% shares of Kehua Bio, and the largest shareholder of Kehua Bio may change.
Kehua Bio announced on the evening of December 14th that Zhuhai Baolian Investment Holding Co., Ltd. (hereinafter referred to as "Zhuhai Baolian"), the largest shareholder, intends to transfer 5% of the shares of the company it holds by public solicitation, and the transfer price is not lower than 20 yuan/share (inclusive). At the same time, it intends to entrust the voting rights corresponding to 10.64% of the shares of the company to the transferee free of charge. If the transfer of public solicitation and the entrustment of voting rights are completed, the largest shareholder of the company may change.
The announcement shows that the public solicitation period is 10 trading days. If the intended transferee meets the requirements, it should submit a full set of application materials to Zhuhai Baolian within 10 trading days from the date of the public solicitation announcement. At present, Zhuhai Baolian holds 95.863 million shares of Kehua Bio, which are non-restricted legal person shares, accounting for 18.64% of the company’s total shares, and it is the largest shareholder of the company, of which 24 million shares are pledged.
It should be noted that this delegation of voting rights is an integral part of this share transfer. After the completion of this transaction, the transferee will directly hold 5% of Kehua (), and control 10.64% of the voting rights of Kehua Bio through voting entrustment, and will control 15.64% of the voting rights in total.
In terms of share transfer price, the arithmetic average daily weighted average price in the 30 trading days before the suggestive announcement date of Kehua Bio-Public Solicitation is 9.02 yuan/share; The audited net asset value per share of Kehua Bio in the latest fiscal year was 9.36 yuan/share. Kehua Bio said that considering various factors, the share transfer price is not lower than 20 yuan/share (inclusive).
Previously, () announced on the evening of December 8 that Zhuhai Baolian, a wholly-owned subsidiary of Zhuhai, intends to transfer 5% of the shares of Kehua Bio through public solicitation of the transferee, corresponding to 25,714,900 shares of Kehua Bio. At the same time, in order to ensure the governance structure and stable operation of Kehua Bio, Zhuhai Baolian intends to entrust its voting rights corresponding to 10.64% shares of Kehua Bio to the transferee of this public solicitation and transfer.
This is the second time that gree real estate has planned to transfer its shares in Kehua Bio for three years. In May 2020, gree real estate announced that it would acquire 95.863 million shares of Kehua Bio through Zhuhai Baolian (accounting for 18.63% of the total share capital of Kehua Bio) at a purchase price of 1.726 billion yuan.
At that time, gree real estate once said that the acquisition was "an important measure to take substantial steps in the fields of biomedicine and medical health and to improve and expand the industrial layout of the big health sector according to its own strategic deployment". Kehua Bio said, "Welcome gree real estate to hold the company for a long time, be optimistic about Kehua’s development, and witness the value return brought by Kehua’s growth with all our shareholders".
In May, 2021, gree real estate announced that it planned to transfer 18.63% shares of Kehua Bio to Shengxiang Bio for its own industrial structure and business development, with a transfer price of 1.95 billion yuan. The transaction fell through three months later because the transfer of equity was not completed and "the expectations of all parties to the transaction could not be met".
Deepwater Haina: It is planned to sign a major contract for EOD project.
On the evening of December 14th, Deepwater Haina announced that the company had received the Notice of Winning Bid from Hutubi County Branch of Changji Ecological Environment Bureau, and the company was the winning bidder (the winning social capital party) of the EOD project integrating comprehensive demonstration management and green industry development in Hutubi River Basin of Changji. The company plans to sign a project contract with the government of Hutubi County, Xinjiang for the above project, and the total investment of the project is estimated to be 264 million yuan in the near future. The project cooperation period is 30 years, of which the construction period is 3 years. At the same time, Shenshui Haina announced that Tibet Bochuang, the concerted action of the company’s controlling shareholder and actual controller, intends to provide the company with financial assistance of no more than 30 million yuan. This financial aid is provided by way of loan, without interest and without guarantee.
Wuliangye Group intends to increase its holdings of Wuliangye shares by 400 million to 800 million yuan.
Wuliangye announced on December 14th that Sichuan Yibin Wuliangye Group Co., Ltd. (hereinafter referred to as "Wuliangye Group Company") plans to increase its shares with its own funds through centralized bidding and block trading, and the amount to be increased is not less than 400 million yuan and not more than 800 million yuan.
According to the shareholder information of Wuliangye, up to now, Yibin Development Holding Group Co., Ltd., the controlling shareholder of Wuliangye, directly holds 34.43% of the company’s shares, and Wuliangye Group holds 20.40% of the company’s shares; Yibin Development Holding Group Co., Ltd. and Wuliangye Group are acting in concert, with a total shareholding ratio of 54.83%.
Wuliangye said that the increase plan is based on Wuliangye Group’s confidence in the company’s sustainable and stable development in the future and its recognition of the company’s long-term value.
In addition, the announcement shows that the increase plan does not set a price range, and will gradually implement the increase plan according to the overall trend of the capital market and the reasonable judgment of the company’s stock value.
Ouyang Qianli, secretary-general of the Liquor Branch of the Shandong Association of Individual and Private Enterprises, told the reporter of the Economic Information Daily that the first step for major shareholders to increase their holdings of stocks is to take out real money and use practical actions to boost confidence in the capital market; Secondly, wine companies have abundant cash flow and funds, and have the responsibility to maintain the undervalued stock price, so as to transmit it to the capital market to establish the confidence of "long-term value"; Thirdly, wine companies also hope to enhance investors’ reputation for wine companies’ brands and products through the promotion of stock prices.
According to the third quarterly report in 2023, in the first three quarters, Wuliangye achieved an operating income of 62.536 billion yuan, a year-on-year increase of 12.11%; The net profit was 22.833 billion yuan, a year-on-year increase of 14.24%, which continued to show a steady development trend. In addition to maintaining a steady growth in performance, Wuliangye’s cash flow also remained abundant. In the first three quarters, the net cash flow generated by Wuliangye’s operating activities was 22.389 billion yuan, a year-on-year increase of 107.58%.
*ST Yuebo received the decision on administrative supervision measures from Jiangsu Securities Regulatory Bureau.
() Announcement, the company recently received the Decision of Jiangsu Securities Regulatory Bureau on taking corrective measures against Nanjing Yuebo Power System Co., Ltd. and issuing warning letters to He Jing. The decision stated that:
There are irregularities in the company: First, the review procedures and disclosure obligations of related party transactions have not been fulfilled. Second, the obligation of continuous information disclosure has not been fulfilled. Third, the occupation of non-operating funds of related parties was not disclosed. Fourth, the information disclosure of related parties is inaccurate.
*ST Yuebo received a letter of concern from Jiangsu Securities Regulatory Bureau.
*ST Yuebo announcement, the company recently received the "Jiangsu Securities Regulatory Bureau’s Letter of Concern for Nanjing Yuebo Power System Co., Ltd." issued by Jiangsu Securities Regulatory Bureau.
The letter of regulatory concern pointed out that in 2021 and 2022, Hubei Yuebo Power System Co., Ltd. (referred to as Hubei Yuebo), a holding subsidiary of the company, provided financial support to Shiyan Jiecheng Hydrogen Energy Automobile Co., Ltd. (referred to as Shiyan Jiecheng), with the amounts of 12.0224 million yuan and 16.6830 million yuan respectively. The above-mentioned external financial assistance of the company failed to fulfill the obligations of internal review and temporary information disclosure, which violated the rules of Shenzhen Stock Exchange.
The two performance compensators have not made share compensation for more than three years, and Xunyou Technology’s application for arbitration was supported.
On December 14th, () (300467.SZ, share price of 16.96 yuan, market value of 3.446 billion yuan) announced that it had recently received a dispute from Chengdu Arbitration Commission (hereinafter referred to as Chengdu Arbitration Commission) between the company and Xiamen Yunneng Tiancheng Investment Management Partnership (hereinafter referred to as Tiancheng Investment) and Xiamen Yunneng Tianyu Investment Management Partnership (hereinafter referred to as Tianyu Investment).
The dispute between the three parties dates back to 2017. In 2017, Xunyou Technology acquired 100% equity of Chengdu Lion Roar Technology Co., Ltd. (hereinafter referred to as Lion Roar) by issuing shares and paying cash, with a target price of 2.7 billion yuan. At that time, Xunyou Technology also signed agreements on profit forecast compensation with seven counterparties including Tiancheng Investment and Tianyu Investment. In the end, the cumulative performance of Lion Roar in three years failed to meet the performance commitment. From 2017 to 2019, Lion Roar completed 60.45% of the promised performance in three years.
To this end, in 2020, Xunyou Technology held a board meeting and shareholders’ meeting, and passed a resolution to buy back 27,002,285 shares that should be compensated by seven compensation obligors, including Tianyu Investment and Tiancheng Investment, at the total price of 1 yuan, and cancel them. Later, Xunyou Technology also sent letters of notification to Tianyu Investment and Tiancheng Investment, requiring them to fulfill the obligations of share compensation and cash dividend return in accordance with the relevant agreements on profit forecast compensation. However, until March this year, the above two compensation obligors still failed to fulfill the above obligations. Therefore, Xunyou Technology submitted an arbitration application to Chengdu Arbitration Commission.
According to the latest ruling, firstly, after Xunyou Technology paid 0.21 yuan and 0.06 yuan to Tiancheng Investment and Tianyu Investment respectively, Tiancheng Investment and Tianyu Investment should compensate the company for 5,789,800 shares and 1,654,300 shares held by them before February 1, 2024.
If Tiancheng Investment and Tianyu Investment fail to fulfill the above obligations on schedule, the company may require Tiancheng Investment and Tianyu Investment to assume alternative liability for losses, and the losses to be compensated are: corresponding compensation shares * average trading price of the company’s shares in the 30 trading days before February 1, 2024 (total trading amount of the company’s shares in the 30 trading days before February 1, 2024/total trading amount of the company’s shares in the 30 trading days before February 1, 2024, with a ceiling of 39.55 yuan per share).
Second, Tiancheng Investment and Tianyu Investment should return the cash dividends of 202,600 yuan and 57,900 yuan of the company’s compensation shares within 10 days from the date of service of the award.
Third, Tiancheng Investment and Tianyu Investment should compensate the company for the preservation fee and the preservation insurance fee of 65,800 yuan and 26,300 yuan respectively within 10 days from the date of delivery of the award. In addition, Tiancheng Investment and Tianyu Investment have to bear part of the arbitration fees.
It is worth noting that Xunyou Technology mentioned that as of December 14, the shares held by Tiancheng Investment and Tianyu Investment were frozen by the judiciary due to the dispute over the financial loan contract with AVIC Trust Co., Ltd., and were later frozen due to this arbitration. "There are uncertainties in the execution time and execution amount of the arbitration result, and the impact on the company’s current profit or future profit is still uncertain. The final impact needs to be based on the arbitration execution result."
The subsidiary of Wenke Garden Holdings intends to acquire 100% equity of the two companies to further increase the photovoltaic business.
On December 14th, () announced that Guangdong Jiansheng Green Energy Co., Ltd. (hereinafter referred to as "Jiansheng Green Energy"), a holding subsidiary of the company, planned to acquire 100% equity of Foshan Shengshi Huineng Photovoltaic Power Generation Technology Co., Ltd. (hereinafter referred to as "Foshan Huineng"), and the equity transfer amount was 11.342 million yuan. In addition, Jiansheng Green Energy plans to acquire 100% equity of Zhongshan Shengdi New Energy Technology Co., Ltd. (hereinafter referred to as "Zhongshan Shengdi"), and the equity transfer amount is 1,284,800 yuan.
According to the data, Jiansheng Green Energy was established in March this year with a registered capital of 100 million yuan. At present, Wenke Garden and Guangdong Foneng Power Sales Co., Ltd. hold 65% and 35% respectively, focusing on photovoltaic power plant investment, and at the same time laying out new energy sectors such as energy storage and optical storage charging inspection. In terms of acquisition target, Foshan Huineng’s business scope includes solar power generation technical services, photovoltaic equipment and components sales, etc. The business scope of Zhongshan Shengdi includes the sales of photovoltaic equipment and components.
"Foshan Huineng and Zhongshan Shengdi have their own ready-made distributed photovoltaic power plants, which is one of the reasons for the company’s acquisition." The staff of the securities department of the liberal arts garden told the reporter of Securities Daily.
Wenke Garden said in the announcement that through this acquisition, the company obtained the distributed photovoltaic power station of the target company, with a total installed capacity of about 7.07MW, which will help to improve the overall installed capacity of the company, and will bring stable cash flow to the company and enhance the company’s profitability. At the same time, the project has good economic benefits, which can accumulate project experience for the company, accelerate the growth of new business and form new profit growth points.
According to the announcement, as of August 31, 2023, the total assets of Foshan Huineng reached 26.6606 million yuan, and the revenue and net profit from January to August this year reached 2.1874 million yuan and 2.0837 million yuan respectively, both exceeding the whole year of 2022; Zhongshan Shengdi’s total assets in the first eight months of this year were 2,401,800 yuan, and its revenue and net profit reached 194,500 yuan and 121,900 yuan respectively.
Since the beginning of this year, liberal arts gardens have actively expanded green energy businesses such as photovoltaic and energy storage on the basis of landscape business. The company’s business scope has added photovoltaic equipment and components sales, solar power generation technical services and energy storage technical services.
Previously, the company and Foshan Jianfa Industrial Park Development Co., Ltd. signed the Strategic Cooperation Agreement on Investment in New Energy Services such as Distributed Photovoltaic, which enabled each other to share resources and promote common development in distributed photovoltaic power plants and energy storage facilities.
"The cross-border photovoltaic industry of listed companies in landscape engineering has its own development needs. The landscape engineering industry and the photovoltaic industry have certain synergistic effects. For example, photovoltaic elements can be integrated into the landscape to create photovoltaic gardens. " Zhu Keli, executive director of China Information Association and founding dean of the National Research Institute of New Economics, told the Securities Daily reporter that listed companies in landscape engineering can also broaden their business scope, increase their income sources and improve their profitability through cross-border photovoltaic industry.
Gree real estate will do subtraction again, and the largest shareholder of Kehua Bio will change.
Kehua Bio announced on the evening of December 14th that Zhuhai Baolian Investment Holding Co., Ltd. (hereinafter referred to as "Zhuhai Baolian"), the largest shareholder, intends to transfer 5% of the shares of the company it holds by public solicitation, and the transfer price is not lower than 20 yuan/share (inclusive). At the same time, it intends to entrust the voting rights corresponding to 10.64% of the shares of the company to the transferee free of charge. If the transfer of public solicitation and the entrustment of voting rights are completed, the largest shareholder of the company may change.
The announcement shows that the public solicitation period is 10 trading days. If the intended transferee meets the requirements, it should submit a full set of application materials to Zhuhai Baolian within 10 trading days from the date of the public solicitation announcement. At present, Zhuhai Baolian holds 95.863 million shares of Kehua Bio, which are non-restricted legal person shares, accounting for 18.64% of the company’s total shares, and it is the largest shareholder of the company, of which 24 million shares are pledged.
It should be noted that this delegation of voting rights is an integral part of this share transfer. After the completion of this transaction, the transferee will directly hold 5% of the shares of Kehua Bio, and control 10.64% of the voting rights of Kehua Bio through voting entrustment, and will control 15.64% of the voting rights in total.
Kehua Bio said that considering various factors, the share transfer price is not lower than 20 yuan/share (inclusive).
Earlier, gree real estate announced on the evening of December 8 that Zhuhai Baolian, a wholly-owned subsidiary of Zhuhai, intends to transfer 5% of the shares of Kehua Bio through public solicitation of the transferee, corresponding to 25,714,900 shares of Kehua Bio.
In fact, this is the second time that gree real estate has planned to transfer its shares in Kehua Bio for three years.
In May, 2021, gree real estate announced that it planned to transfer 18.63% shares of Kehua Bio to Shengxiang Bio for its own industrial structure and business development, with a transfer price of 1.95 billion yuan. The transaction fell through three months later because the transfer of equity was not completed and "the expectations of all parties to the transaction could not be met".
The largest shareholder of Kehua Bio publicly solicited the takeover party.
On the evening of December 14th, Kehua Bio announced that Zhuhai Baolian Investment Holding Co., Ltd., the largest shareholder of the company, intends to transfer 5% of its shares through public solicitation of the transferee, and the share transfer price is not lower than 20 yuan/share (inclusive). At the same time, in order to ensure the corporate governance structure and stable operation, it is planned to entrust the voting rights corresponding to its 10.64% shares to the transferee free of charge. If the transfer of public solicitation and the entrustment of voting rights are completed, the largest shareholder of the company may change.
The announcement shows that the intended transferee should be a single legal entity (limited to corporate legal person or partnership) and must independently transfer all the shares to be transferred. The intended transferee accepts the entrustment of voting rights corresponding to 10.64% of the total share capital of Kehua Bio held by Zhuhai Baolian while accepting the shares. The intended transferee or its actual controller shall have a profound background in in-vitro diagnosis industry and rich experience in in-vitro diagnosis industry. The intended transferee shall put forward effective measures or schemes to promote the sustained and coordinated development of listed companies and their subsidiaries, introduce effective strategic resources such as management, technology, market or industrial coordination for listed companies, and assist listed companies to enhance their industrial competitiveness.
At present, Zhuhai Baolian holds 95.863 million shares of Kehua Bio, which are non-restricted legal person shares, accounting for 18.64% of the total shares of Kehua Bio, and it is the largest shareholder of Kehua Bio, of which 24 million shares are pledged.
This delegation of voting rights is an integral part of this share transfer. After the completion of this transaction, the transferee will directly hold 5% of the shares of Kehua Bio, and control 10.64% of the voting rights of Kehua Bio through voting entrustment, and will control 15.64% of the voting rights in total. Considering various factors, the share transfer price is not lower than 20 yuan/share (inclusive). Kehua Bio closed at 8.88 yuan on the 14th.
According to the announcement, the public solicitation period is 10 trading days. If the intended transferee meets the requirements, it should submit a full set of application materials to Zhuhai Baolian within 10 trading days from the date of the public solicitation announcement.
Deepwater Haina: The company plans to sign a major contract for daily operation.
Haina in Deepwater announced that the company has received the Notice of Winning Bid from Hutubi County Branch of Changji Ecological Environment Bureau. The company is the winning bidder (the winning social capital party) of the EOD project (tender number: 2023XJHDHTB-066) integrating comprehensive demonstration management and green industry development in Hutubi River Basin in Changji. The Company and the People’s Government of Hutubi County, Xinjiang intend to sign the EOD Project Contract for Integrated Ecological Demonstration and Green Industry Development in Hutubi River Basin of Changji Prefecture. The total investment of this project is estimated to be 264 million yuan in the near future.
*ST three sheng receives the letter of concern from Shenzhen Stock Exchange, and the company and related parties will be initiated disciplinary proceedings.
On December 14th, () announced that it had received a letter of concern from Shenzhen Stock Exchange. Due to the violation of the relevant regulations of the Shenzhen Stock Exchange, the Shenzhen Stock Exchange decided to initiate disciplinary proceedings against the company and related parties. At the same time, the Shenzhen Stock Exchange also requires the company to explain and reply in writing on matters related to the follow-up settlement arrangements for illegal guarantees.
Prior to this, *ST three sheng disclosed on December 13th that he had received the Notice of Administrative Punishment in advance issued by Beijing Supervision Bureau of China Securities Regulatory Commission (hereinafter referred to as the "Notice"), and the important matters mentioned in it were also related to the company’s illegal guarantee.
In this regard, industry sources interviewed by the Securities Daily reporter said that listed companies should keep in mind compliance management and the key minority should standardize their duties if there are repeated violations of guarantees or internal control failures on behalf of the company.
Violation of guarantees often occurs.
According to the notice, from 2020 to 2021, Guangdong three sheng Smart Education Technology Investment Co., Ltd. (hereinafter referred to as "Guangdong three sheng"), a wholly-owned subsidiary of *ST three sheng, illegally provided external guarantees by means of deposit pledge, and did not fully disclose the relevant major guarantees during the reporting period in the 2020 annual report and the 2021 semi-annual report, resulting in the existence of the company’s 2020 annual report and the 2021 semi-annual report.
In view of the behavior of the company and relevant responsible persons, the Beijing Supervision Bureau of China Securities Regulatory Commission intends to give a warning to the company and impose a fine of 1.1 million yuan; Give a warning to Lin Rongbin and impose a fine of 1.9 million yuan, including 1.2 million yuan as the actual controller and 700,000 yuan as the directly responsible person in charge; Cao Lei, deputy general manager, was given a warning and fined 600,000 yuan.
In addition, *ST three sheng also disclosed an announcement on November 29th, in which it was mentioned that Hunan three sheng New Energy Co., Ltd., a wholly-owned subsidiary, provided a pledge guarantee to its affiliated company or designated company with the bank time deposit certificate as the actual controller, but failed to perform the deliberation and decision-making procedures of the company’s board of directors and shareholders’ meeting, and Hunan three sheng New Energy Co., Ltd., a wholly-owned subsidiary of the company, provided a guarantee in violation of regulations. As of September 11th, Hunan three sheng New Energy Co., Ltd. was forcibly transferred by the bank. In addition, *ST three sheng related party, Hunan Hongkun Building Materials Co., Ltd., etc., totally occupied the company’s capital of 200 million yuan.
Lawyer Wang Zhibin of Shanghai Minglun Law Firm told the Securities Daily reporter that as early as 2020, nearly 800 million yuan of illegal guarantee occurred in *ST three sheng, and the pledge was lifted because the debtor paid off the debt, which did not produce the actual guarantee responsibility. However, this did not make *ST three sheng take a warning, but laid the groundwork for the next illegal guarantee.
According to Wang Zhibin’s analysis, from the perspective of information disclosure, the relevant behavior of the company has touched the provisions of Article 85 of the Securities Law. With the issuance of the notice, investors can file a civil claim lawsuit against listed companies and actual controllers, demanding securities trading to compensate for the loss of investment difference, commission loss and stamp duty loss. Among them, the loss of investment difference can be understood as the bubble cost that investors spend more on the bubble price, and the amount of investment difference loss is related to the purchase price and the number of shares.
Supervision pays attention to follow-up settlement arrangements
In the letter of concern issued on December 14, Shenzhen Stock Exchange asked the company to explain the follow-up settlement arrangements for illegal guarantees, the actual situation and restrictions of the company’s monetary fund balance so far; Up to now, the recovery measures taken by the company for the transferred funds of 450 million yuan and the funds occupied by 200 million yuan, the follow-up arrangements and time limit for the company and its related parties to solve the illegal guarantees and funds occupied, and the further measures to be taken by the company if they are still unresolved at maturity, self-check and explain whether there are defects in the internal control related to financial reporting, and further improve the relevant measures of internal control; Whether the company has other undisclosed capital occupation or illegal guarantee matters that should be disclosed.
"*ST three sheng did not disclose major guarantees in time, resulting in false records in the company’s regular reports, and the relevant directors did not play their due role." Wang Peng, an associate researcher at the Beijing Academy of Social Sciences, told the Securities Daily that if some listed companies still have luck, it will not be conducive to the future development of the company.
* 2.77% of the shares held by ST Xifa shareholder Tianyi Longxing were reduced to less than 5% by judicial auction.
() Announced, the company inquired through the system of China Securities Depository and Clearing Co., Ltd. Shenzhen Branch that 7,299,600 shares (accounting for 2.77% of the company’s total share capital) of Tibet Tianyi Longxing Investment Co., Ltd. (referred to as "Tianyi Longxing"), which held more than 5% of the company’s shares, had been judicially auctioned. After this equity change, Tianyi Longxing holds 7.8 million shares of the company, accounting for 2.96% of the total shares of the company, and no longer belongs to shareholders holding more than 5% of the company’s shares.
The controlling shareholder of Feikai Materials, etc., is planned to be fined more than 10 million yuan for allegedly violating the laws and regulations related to shareholding changes.
() Announced that the controlling shareholder of the company, Feikai Holdings Co., Ltd. (hereinafter referred to as "Feikai Holdings") and its concerted action person, Zhang Yanxia, respectively received the Notice of Filing a Case issued by the China Securities Regulatory Commission on November 3, 2023. Due to the alleged violation of laws and regulations related to shareholding change, China Securities Regulatory Commission decided to file a case against Feikai Holdings and Zhang Yanxia according to the Securities Law of People’s Republic of China (PRC) and the Administrative Punishment Law of the People’s Republic of China.
On December 14, 2023, the company received the notice from Feikai Holdings and its actual controllers ZHANG JINSHAN and Zhang Yanxia, and on December 14, 2023, it received the Notice of Administrative Punishment in advance issued by Shanghai Supervision Bureau of China Securities Regulatory Commission.
It is reported that Feikai Holdings and its concerted parties jointly hold more than 5% of the shares of Feikai Materials. When the related large-scale transactions of Feikai Holdings led to a total reduction of 5% of the shares held by the concerted parties, Feikai Holdings failed to fulfill its reporting and announcement obligations as required, which was suspected of violating the provisions of the second paragraph of Article 63 of the Securities Law and constituting the illegal act mentioned in the first paragraph of Article 197 of the Securities Law. ZHANG JINSHAN is the actual controller of Feikai Holdings, the decision-maker of the above-mentioned Feikai Holdings transaction, and the person in charge who is directly responsible for Feikai Holdings’ failure to submit relevant reports and fulfill its information disclosure obligations.
The transfer of shares of Feikai Materials by Feikai Holdings and Zhang Yanxia during the restricted transfer period is suspected of violating the provisions of the first paragraph of Article 36 of the Securities Law, and is suspected of constituting an illegal act mentioned in Article 186 of the Securities Law. The Shanghai Supervision Bureau intends to decide: 1. Give a warning to Feikai Holdings for failing to submit relevant reports and fulfill its information disclosure obligations as required, and impose a fine of 2 million yuan. ZHANG JINSHAN, the person in charge who is directly responsible for Feikai Holdings’ failure to submit relevant reports and fulfill its information disclosure obligations, was given a warning and fined 500,000 yuan. 2. Give a warning to Feikai Holdings and Zhang Yanxia for transferring shares of Feikai Materials during the restricted transfer period, confiscate the illegal income of 970,900 yuan and impose a fine of 6.7 million yuan. Among them, Feikai Holdings was given a warning, the illegal income was confiscated 970,900 yuan, and a fine of 6.2 million yuan was imposed; Zhang Yanxia was given a warning and fined 500,000 yuan.
Feikai Material: The controlling shareholder and others are planned to be fined more than 10 million yuan for being suspected of violating laws and regulations related to shareholding changes.
Feikai Materials announced that Feikai Holdings Limited (hereinafter referred to as "Feikai Holdings"), the controlling shareholder of the company, and Zhang Yanxia, its concerted action, received the Notice of Filing a Case issued by China Securities Regulatory Commission on November 3, 2023, respectively. China Securities Regulatory Commission decided to file a case against Feikai Holdings and Zhang Yanxia according to the Securities Law of People’s Republic of China (PRC), the Administrative Punishment Law of the People’s Republic of China and other laws and regulations.
The total investment is 2.1 billion! The company continues to add photovoltaic cells.
On the evening of December 14th, Aikang Technology announced that it planned to invest 2.1 billion yuan to build six HJT (heterojunction) battery production lines with a total production capacity of 4.6GW. The reporter noted that in April this year, the company disclosed the plan of fixed increase, and planned to raise 300 million yuan to invest in Huzhou Aikang 2.42GW high-efficiency heterojunction photovoltaic cell construction project.
Six new production lines are planned.
According to the announcement, Aikang Technology has the production capacity of 3.2GW HJT battery, 0.8GW PERC battery and 10.4GW module through the layout of four high-efficiency solar module production bases in Suzhou, Jiangsu, Ganzhou, Jiangxi, Huzhou, Zhejiang and Zhoushan, Zhejiang.
Up to now, the order for HJT components of Aikang Technology is about 2.95GW, and the company’s own production capacity of HJT batteries cannot meet the order demand. According to the company’s strategic plan, Ganzhou Aikang Photoelectric Technology Co., Ltd., its wholly-owned grandson company, plans to invest in the construction of a 4.6GW HJT battery production project, with a total investment of 2.1 billion yuan in fixed assets, and a new 600MW and five 800MW HJT battery production lines.
Aikang Technology said that this production plan is to expand production by sales, combine market and customer demand forecasts, and increase production capacity by order in batches and line by line, and the completion time is consistent with the increase of orders in the market. The company plans to complete the entry of the main equipment of the first HJT battery production line in January 2024.
Aikang Technology said in the announcement that this investment in the 4.6GW HJT battery production project, the planned main product HJT battery sheet has the advantages of good power generation performance, great potential for efficiency improvement, clear cost reduction path and simplified process flow compared with the current mainstream products in the market. The company will continue to increase the manufacturing of high-efficiency solar cell modules, focus on heterojunction technology, and further upgrade the battery production line. In the new round of competition for upgrading P-type to N-type technologies in the photovoltaic industry, it is expected to continue to gain a favorable market competitive position by virtue of its capacity structure advantages.
It is planned to realize 40GW production capacity within five years.
The reporter noticed that in April this year, Aikang Technology had thrown out a plan to issue shares to specific targets by simple procedures, and the planned fundraising was no more than 300 million yuan, all of which were invested in Huzhou Aikang 2.42GW high-efficiency heterojunction photovoltaic cell construction project.
It is reported that the project plans to introduce a series of battery production equipment, equipped with corresponding testing and experimental equipment, to achieve an annual production capacity of 2.42GW of high-efficiency heterojunction photovoltaic cells. The project is implemented in two phases, the first phase is to build a 0.82GW high-efficiency heterojunction photovoltaic cell project, and the second phase is to build a 1.6GW high-efficiency heterojunction photovoltaic cell project, which is scheduled to be completed in the fourth quarter of 2023.
In terms of capacity planning, Aikang Technology said in the semi-annual report in 2023 that through the layout of several high-efficiency bases such as Suzhou, Huzhou, Ganzhou, Zhoushan and Wuxi, it is planned to realize the production capacity of over 40GW of high-efficiency solar cells and components within five years.
In terms of product performance, the company said in the semi-annual report that the average conversion efficiency of mass production of Aikang single-sided microcrystalline heterojunction batteries is 25.3%-25.5%, the highest batch can exceed 25.6%, and the production yield is 98%. It is expected that the mass production of double-sided microcrystalline heterojunction batteries will be introduced in the fourth quarter, and the average conversion efficiency is expected to exceed 25.6%-25.7%, which is in the leading position in the industry.
It is expected to usher in further expansion.
Since the fourth quarter, the news that heterojunction battery projects have been put into production has continued. On December 12th, () holding subsidiary Honghui New Energy (Anhui) Co., Ltd. held the ignition and commissioning ceremony of "10GW single crystal silicon wafer project for heterojunction batteries" in Xuancheng, Anhui.
According to the news from the Academia Sinica of Guodian Investment, on November 24th, the commissioning and the first delivery ceremony of the 5GW high-efficiency heterojunction battery and component mass production base of Guodian Investment was held in Longgang City, Wenzhou, Zhejiang Province, and the first batch of high-efficiency heterojunction component products were delivered to customers one after another.
Xu Xiaohua, chairman of Huasheng New Energy, said at the 2023 annual meeting of photovoltaic industry held on December 14th that after several years’ development, heterojunction technology has achieved large-scale and low-cost mass production and supply. In recent years, the yield of heterojunction from equipment to raw materials has been continuously improved, and it is very fast for heterojunction to leap into the mainstream platform. It is expected that some leading enterprises will expand production next year.
It is worth noting that cost reduction has always been one of the core problems faced by heterojunction batteries. SMM previously predicted that heterojunction batteries are expected to be mass-produced at a lower cost per watt than PERC/TOPCon batteries by 2025. Not long ago, Xu Xiaohua also said that in 2024, with the mass production of special rod pulling technology for heterojunction, the production cost of HJT’s entire industrial chain is expected to be lower than TOPCon.
International composite materials need to be allocated with a market value of 980,000 yuan to purchase the top grid today.
According to the announcement of the exchange, international composite materials are subscribed today, with the subscription code of 301526 and the issue price of 2.66 yuan/share. The maximum subscription limit for a single account is 98,000 shares, and the top subscription requires a market value of 980,000 yuan.